Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (690 visite)

Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J

Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.



Tipo di articolo: Journal Article,

Impact factor: 19.358, Impact factor a 5 anni: 24.124

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890846621&partnerID=40&md5=35f1d5e04540eff09ba6ff76c5326625

Parole chiave: Antineoplastic Agent, Diazoxide, Glucocorticoid, Growth Hormone, Human Monoclonal Antibody, Insulin, Insulin Receptor, Mannose 6 Phosphate, Neuroleptic Agent, Octreotide, Phosphotransferase Inhibitor, Protein Tyrosine Kinase, Somatomedin B, Somatomedin Binding Protein, Somatomedin C Receptor, Somatostatin, Acromegaly, Adjuvant Therapy, Adrenal Cortex Carcinoma, Angiosarcoma, Bile Duct Tumor, Cancer Chemotherapy, Cancer Radiotherapy, Cancer Therapy, Clear Cell Sarcoma, Clinical Feature, Colon Tumor, Cytoreductive Surgery, Diagnostic Procedure, Diet Restriction, Dysgerminoma, Electroconvulsive Therapy, Endocrine Surgery, Esophagus Tumor, Fibroma, Fibrosarcoma, Gene Control, Growth Hormone Blood Level, Hemangioendothelioma, Hemangiopericytoma, Hormone Metabolism, Hypoglycemia, Immunoassay, Insulin Blood Level, Insulinoma, Laboratory, Leukemia, Liposarcoma, Liver Cell Carcinoma, Lung Tumor, Lymphoma, Lymphosarcoma, Melanoma, Meningioma, Mesoblastic Nephroma, Mesothelioma, Myeloma, Neurilemoma, Neuroblastoma, Neurofibroma, Neurofibrosarcoma, Non Islet Cell Tumor Hypoglycemia, Nonhuman, Pancreas Islet Cell Tumor, Pancreas Tumor, Pathophysiology, Peritoneum Pseudomyxoma, Priority Journal, Protein Binding, Protein Blood Level, Protein Degradation, Protein Function, Radioimmunoassay, Rectum Tumor, Reticulosarcoma, Review, Rhabdomyosarcoma, Schizophrenia, Seminoma, Signal Transduction, Stomach Tumor, Target Cell, Teratoma, Animals, Autoimmunity, Insulin-Like Growth Factor Binding Proteins, Igf Type 1,

Affiliazioni:

*** IBB - CNR ***
Queens Long Island Medical Group, North Shore-Long Island Jewish (NS-LIJ) Health System, Hicksville, NY 11801, United States
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, United States
Laboratory of Diabetes and Diabetes-Related Research, Feinstein Institute for Medical Research, NS-LIJ Health System, Manhasset, NY 11030, United States
Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, United States
Division of Endocrinology, Diabetes, and Metabolism, New York University, School of Medicine, New York 10016, NY, United States
Veterans Administration New York Harbor Healthcare System, New York 10010, NY, United States
Hofstra NS-LIJ School of Medicine, NS-LIJ Health System, Manhasset, NY 11549, United States
Endocrinology and Metabolism, Geisinger Health System, State College, Pennsylvania 16801, United States
Endocrine Associates of Long Island, Smithtown, NY 11787, United States
Stony Brook University Hospital, Stony Brook, NY 11794, United States
Diabetes and Metabolism Clinical Research Center of Excellence, Clinical Research Institute at Rambam, Haifa 31096, Israel
Endocrine Unit, Department of Clinical and Molecular Biomedicine, University of Catania, Garibaldi-Nesima Hospital, Catania, Italy
Istituto di Biostrutture e Bioimmagini-Consilgio Nazionale delle Richerche Catania Section, Catania 95131, Italy



Riferimenti:

Koch, C.A., Rother, K.I., Roth, J., Tumor hypoglycemia linked to IGF-II. The IGF System: Molecular Biology, Physiology, and Clinical Applications. Totowa , 1999, pp. 675-698. , NJ: Humana Press

Rosenfeld RG, Roberts CT, edsNadler, W.H., Wolfer, J.A., Hepatogenic hypoglycemia associated with primary liver cell carcinoma (1929) Arch Intern Med, 44, pp. 700-71

Elliot, C.A., Hepatic hypoglycemia associated with primary liver cell carcinoma (1929) Trans AssocAmPhysicians, 44, pp. 121-126

McFadzean, A.J., Yeung, R.T., Further observations on hypoglycaemia in hepatocellular carcinoma (1969) Am J Med, 47, pp. 220-235

LeRoith, D., Roberts Jr., C.T., The insulin-like growth factor system and cancer (2003) Cancer Lett, 195, pp. 127-137

LeRoith, D., Non-islet cell hypoglycemia (2004) Ann Endocrinol (Paris), 65, pp. 99-103

Herrmann, B.L., Saller, B., Kiess, W., Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia (2000) Exp Clin Endocrinol Diabetes, 108, pp. 515-518

Empen, K., Otto, C., Müller-Höcker, J., Zapf, J., Schwandt, P., Case 1 hypoglycemic syncope due to a peripheral neuroectodermal tumor (2000) J Clin Oncol, 18, pp. 1594-1596

Yoshida, D., Sugisaki, Y., Tamaki, T., Intracranial malignant meningioma with abdominal metastases associated with hypoglycemic shock: a case report (2000) J Neurooncol, 47, pp. 51-58

Baker, J.L., Aleman, M., Madigan, J., Intermittent hypoglycemia in a horse with anaplastic carcinoma of the kidney (2001) J Am Vet Med Assoc, 218, pp. 235-237

Berman, J., Harland, S., Hypoglycaemia caused by secretion of insulin-like growth factor 2 in a primary renal cell carcinoma (2001) Clin Oncol (R Coll Radiol), 13, pp. 367-369

Corti, B., Carella, R., Gabusi, E., D'Errico, A., Martorana, G., Grigioni, W.F., Solitary fibrous tumour of the urinary bladder with expression of bcl-2, CD34, and insulin-like growth factor type II (2001) Eur Urol, 39, pp. 484-488

Eguchi, T., Tokuyama, A., Tanaka, Y., Hypoglycemia associated with the production of insulin-like growth factor II in adrenocortical carcinoma (2001) Intern Med, 40, pp. 759-763

Kim, J.H., Kim, J.O., Kim, S.Y., Na, M.H., Lim, S.P., Kim, J.M., Two cases of large solitary fibrous tumors of the pleura associated with fasting hypoglycemia (2001) Eur Radiol, 11, pp. 819-824

Kishi, K., Homma, S., Tanimura, S., Matsushita, H., Nakata, K., Hypoglycemia induced by secretion of high molecular weight insulin-like growth factor-II from a malignant solitary fibrous tumor of the pleura (2001) Intern Med, 40, pp. 341-344

Matsuda, S., Usui, M., Sakurai, H., Suzuki, H., Ogura, Y., Shiraishi, T., Insulin-like growth factor II-producing intra-abdominal hemangiopericytoma associated with hypoglycemia (2001) J Gastroenterol, 36, pp. 851-855

Rena, O., Filosso, P.L., Papalia, E., Solitary fibrous tumour of the pleura: surgical treatment (2001) Eur J Cardiothorac Surg, 19, pp. 185-189

Filosso, P.L., Oliaro, A., Rena, O., Papalia, E., Ruffini, E., Mancuso, M., Severe hypoglycaemia associated with a giant solitary fibrous tumor of the pleura (2002) J Cardiovasc Surg (Torino), 43, pp. 559-561

Nanayakkara, P.W., van Doorn, J., van den Berg, F.G., van Groeningen, C.J., Pinedo, H.M., Hoekman, K., Treatment of haemangiopericytoma-associated hypoglycemia with embolisation (2002) Eur J Intern Med, 13, pp. 340-343

van Wijngaarden, P., Janssen, J.A., de Man, R.A., [Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia] (2002) Ned Tijdschr Geneeskd, 146, pp. 859-862. , (Dutch)

Beckers, M.M., Slee, P.H., van Doorn, J., Hypoglycaemia in a patient with a gastrointestinal stromal tumour (2003) Clin Endocrinol (Oxf), 59, pp. 402-404

Ikeda, K., Mizuguchi, M., Yoshida, H., Preclinical Cushing's syndrome associated with non-islet cell tumor hypodoiglycemia

an additional report (2003) Intern Med, 42, pp. 1151-1152

Morgan, M., Nanzer, A., Camacho-Hubner, C., Kaltsas, G.A., Monson, J.P., Hypoglycaemia secondary to the secretion of pro-insulin like growth factor II by a metastatic neuroendocrine tumour with sarcomatous differentiation (2003) Hormones (Athens), 2, pp. 125-129

Plikat, K., Reichle, A., Elmlinger, M.W., Schölmerich, J., [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma] (2003) Deutsche Medizinische Wochenschrift, 128, pp. 257-260

Alsafadi, H., Ansari, H., Biggs, P., Randeva, H.S., Unusual site and presentation of a neuroendocrine tumour (2004) Hosp Med, 65, pp. 564-565

Kageyama, K., Moriyama, T., Hizuka, N., Hypoglycemia associated with big insulin-like growth factor II produced during development of malignant fibrous histiocytoma (2003) Endocr J, 50, pp. 753-758

Kato, A., Bando, E., Shinozaki, S., Severe hypoglycemia and hypokalemia in association with liver metastases of gastric cancer (2004) Intern Med, 43, pp. 824-828

Kumar, S., Yushak, A.W., Gul, Y.A., Intraabdominal haemangiopericytoma associated with uncontrolled diabetes mellitus (2004) Med J Malaysia, 59, pp. 425-427

Miyamoto, S., Matsuda, W., Tsunoda, T., Sasaki, M., Itabashi, M., [Multiple extracranial metastases from a meningeal hemangiopericytoma and severe hypoglycemia: a case report] (2004) No Shinkei Geka, 32, pp. 367-372. , (Japanese)

Morbois-Trabut, L., Maillot, F., De Widerspach-Thor, A., Lamisse, F., Couet, C., "Big IGF-II"-induced hypoglycemia secondary to gastric adenocarcinoma (2004) Diabetes Metab, 30, pp. 276-279

Sato, R., Tsujino, M., Nishida, K., High molecular weight form insulin-like growth factor II-producing mesenteric sarcoma causing hypoglycemia (2004) Intern Med, 43, pp. 967-971

Stein, R.H., Herman, S.D., Phelps, R.G., Sapadin, A.N., Florid eruption of seborrheic keratoses associated with elevated insulin-like growth factor, hypoglycemia, and solitary fibrous tumor of the pleura (2004) Int J Dermatol, 43, pp. 944-947

Kafih, M., Boubia, S., Ridai, M., [Hypoglycemic coma revealing a solitary fibrous tumor of the pleura] (2005) Presse Med, 34, p. 1370. , (French)

Pink, D., Schoeler, D., Lindner, T., Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases (2005) J Clin Oncol, 23, pp. 6809-6811

Rikhof, B., Van Den Berg, G., Van Der Graaf, W.T., Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour (2005) Acta Oncol, 44, pp. 764-766

Tsurukawa, H., Komura, H., Hirata, T., [Solitary fibrous tumor presenting as perivesical mass associated with hypoglycemia: a case report] (2005) Nihon Hinyokika Gakkai Zasshi, 96, pp. 709-713. , (Japanese)

Wakami, K., Tateyama, H., Kawashima, H., Solitary fibrous tumor of the uterus producing high-molecularweight insulin-like growth factor II and associated with hypoglycemia (2005) Int J Gynecol Pathol, 24, pp. 79-84

de Boer, J., Jager, P.L., Wiggers, T., The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient (2006) Int J Clin Oncol, 11, pp. 478-481

Fernando, H.S., Hawkyard, S.J., Poon, P., Musa, M., Renal cell carcinoma with non-islet cell tumor hypoglycemia (2006) Int J Urol, 13, pp. 985-986

Fukuda, I., Hizuka, N., Ishikawa, Y., Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia (2006) GrowthHormIGF Res, 16, pp. 211-216

Guiteau, J., Fanucchi, M., Folpe, A., Staley, C., Hypoglycemia in the setting of advanced gastrointestinal stromal tumor (2006) Am Surg, 72, pp. 1225-1230. , 3rd Kooby DA

Hamberg, P., de Jong, F.A., Boonstra, J.G., vanDoorn, J., Verweij, J., Sleijfer, S., Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib (2006) J Clin Oncol, 24, pp. e30-e31

Hirai, A., Nakanishi, R., Solitary fibrous tumor of the pleura with hypoglycemia associated with serum insulin-like growth factor II (2006) J Thorac Cardiovasc Surg, 132, pp. 713-714

Soran, H., Younis, N., Joseph, F., Hayat, Z., Zakhour, H., Scott, A., Acase of haemangiopericytoma-associated hypoglycaemia: Beneficial effect of treatment with radiotherapy (2006) Int J Clin Pract, 60, pp. 1319-1322

Tsuro, K., Kojima, H., Okamoto, S., Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-II-producing solitary fibrous tumor (2006) Intern Med, 45, pp. 525-529

Aguiar Bujanda, D., Rivero Vera, J.C., Cabrera Suá rez, M.A., Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast (2007) Breast J, 13, pp. 189-191

Chan, G., Horton, P.J., Thyssen, S., Malignant transformation of a solitary fibrous tumor of the liver and intractable hypoglycemia (2007) J Hepatobiliary Pancreat Surg, 14, pp. 595-599

Chang, J.C., Su, K.Y., Chao, S.F., Hsu, Y.H., Yang, G.G., Chang, B.S., Hypoglycemia in a patient with a huge malignant solitary fibrous tumor of the pleura (2007) Pathol Int, 57, pp. 791-793

Davda, R., Seddon, B.M., Mechanisms and management of non-islet cell tumour hypoglycemia in gastrointestinal stromal tumour: case report and a review of published studies (2007) Clin Oncol (R Coll Radiol), 19, pp. 265-268

de Groot, J.W., Rikhof, B., van Doorn, J., Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases (2007) Endocr Relat Cancer, 14, pp. 979-993

Escobar, G.A., Robinson, W.A., Nydam, T.L., Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report (2007) BMC Cancer, 7, p. 13

Kameyama, K., Okumura, N., Kokado, Y., Miyoshi, K., Matsuoka, T., Nakagawa, T., Solitary fibrous tumor associated with non-islet cell tumor hypoglycemia (2007) Ann Thorac Surg, 84, pp. 292-294

Kanzaki, M., Kashihara, H., Kiura, K., Severe hypoglycemia induced by IGF-II producing non-islet cell tumor (2007) Intern Med, 46, p. 1061

Nauck, M.A., Reinecke, M., Perren, A., Hypoglycemia due to paraneoplastic secretion of insulin-like growth fac-tor-I in a patient with metastasizing large-cell carcinoma of the lung (2007) J Clin Endocrinol Metab, 92, pp. 1600-1605

Chung, J.O., Hong, S.I., Cho, D.H., Lee, J.H., Chung, D.J., Chung, M.Y., Hypoglycemia associated with the production of insulin-like growth factor II in a pancreatic islet cell tumor: a case report (2008) Endocr J, 55, pp. 607-612

Fama, F., Le Bouc, Y., Barrande, G., Solitary fibrous tumour of the liver with IGF-II-related hypoglycaemia (2008) A case report. Langenbecks Arch Surg., 393, pp. 611-616

Hall, K.F., Lin, C.L., Wang, T.H., Chang, R.H., Chen, H.M., A case of gastrointestinal stromal tumor with hyperinsulinemic hypoglycemia (2008) Chang Gung Med J, 31, pp. 107-111

Tani, Y., Tateno, T., Izumiyama, H., Doi, M., Yoshimoto, T., Hirata, Y., Defective expression of prohormone convertase 4 and enhanced expression of insulin-like growth factor II by pleural solitary fibrous tumor causing hypoglycemia (2008) Endocr J, 55, pp. 905-911

Marks, V., Rose, F.C., Extra-pancreatic neoplasms , 1981, pp. 246-266. , Hypoglycemia. Oxford, UK: Blackwell Scientific PublicationsBriselli, M., Mark, E.J., Dickersin, G.R., Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature (1981) Cancer, 47, pp. 2678-2689

England, D.M., Hochholzer, L., McCarthy, M.J., Localized benign and malignant fibrous tumors of the pleura A clinicopathologic review of 223 cases (1989) AmJ Surg Pathol, 13, pp. 640-658

Wasada, T., Hizuka, N., Yamamoto, M., An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms (1992) Metabolism, 41, pp. 310-316

Trivedi, N., Mithal, A., Sharma, A.K., Non-islet cell tumour induced hypoglycemia with acromegaloid facial and acral swelling (1995) Clin Endocrinol (Oxf), 42, pp. 433-435

Mayou, S.C., Benn, J.J., Sonksen, P.H., Black, M.M., Paraneoplastic rhinophyma and the Leser-Trélat sign (1989) Clin Exp Dermatol, 14, pp. 253-255

Lawson, E.A., Zhang, X., Crocker, J.T., Wang, W.L., Klibanski, A., Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma (2009) J Clin Endocrinol Metab, 94, pp. 2226-2231

Dizon, A.M., Kowalyk, S., Hoogwerf, B.J., Neuroglycopenic and other symptoms in patients with insulinomas (1999) Am J Med, 106, pp. 307-310

Crocker, D.W., Veith, F.J., Mesodermal tumors associated with hypoglycemia: review of literature and report of a case (1965) Ann Surg, 161, pp. 418-427

Deary, I.J., Symptoms of hypoglycaemia and effects on mental performance and emotions Hypoglycaemia in Clinical Diabetes, 2007, pp. 25-48. , Frier BM, Fisher M, eds New York, NY: Wiley

Cryer, P.E., Hypoglycemia, functional brain failure, and brain death (2007) J Clin Invest, 117, pp. 868-870

Malouf, R., Brust, J., Hypoglycemia: causes, neurological manifestations, and outcome (1985) Ann Neurol, 17, pp. 421-430

Amiel, S.A., Sherwin, R.S., Simonson, D.C., Tamborlane, W.V., Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release (1988) Diabetes, 37, pp. 901-907

Boyle, P.J., Schwartz, N.S., Shah, S.D., Clutter, W.E., Cryer, P.E., Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics (1988) NEngl J Med, 318, pp. 1487-1492

Mitrakou, A., Fanelli, C., Veneman, T., Reversibility of unawareness of hypoglycemia in patients with insulinomas (1993) N Engl J Med, 329, pp. 834-839

Cryer, P.E., Axelrod, L., Grossman, A.B., Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline (2009) J Clin Endocrinol Metab, 94, pp. 709-728

Cahill Jr., G.F., Herrera, M.G., Morgan, A.P., Hormonefuel interrelationships during fasting (1966) J Clin Invest, 45, pp. 1751-1769

Stanley, C.A., Baker, L., Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia (1976) Pediatrics, 57, pp. 702-711

Zapf, J., Role of insulin-like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumour hypoglycaemia (1993) J Intern Med, 234, pp. 543-552

Eastman, R.C., Carson, R.E., Orloff, D.G., Glucose utilization in a patient with hepatoma and hypoglycemia Assessment by a positron emission tomography (1992) J Clin Invest, 89, pp. 1958-1963

Møller, N., Blum, W.F., Mengel, A., Hansen, L.B., Alberti, K.G., Schmitz, O., Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia

evidence for increased muscle glucose uptake (1991) Diabetologia, 34, pp. 17-20

Fehmann, H.C., Jehle, P., Markus, U., Göke, B., Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells (1996) Metabolism, 45, pp. 759-766

LeRoith, D., Clemmons, D., Nissley, P., Rechler, M.M., NIH conference Insulin-like growth factors in health and disease (1992) Ann Intern Med, 116, pp. 854-862

Thakker, R.V., Multiple endocrine neoplasia type 1.Principles of Molecular Medicine. Totowa , 2006, pp. 386-392. , NJ: Humana Press

Runge MS, Patterson C, edsGrunberger, G., Weiner, J.L., Silverman, R., Taylor, S., Gorden, P., Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up (1988) Ann Intern Med, 108, pp. 252-257

Service, F.J., Factitial hypoglycemia (1992) Endocrinologist, 2, pp. 173-176

Lebowitz, M.R., Blumenthal, S.A., The molar ratio of insulin to C-peptide An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration (1993) Arch Intern Med, 153, pp. 650-655

Whipple, A.O., The surgical therapy of hyperinsulinism (1938) J Int Chir, 3, pp. 237-276

Whipple, A.O., Present-day surgery of the pancreas (1942) N Engl J Med, 226, pp. 515-526

Astles, J.R., Petros, W.P., Peters, W.P., Sedor, F.A., Artifactual hypoglycemia associated with hematopoietic cytokines (1995) Arch Pathol Lab Med, 119, pp. 713-716

Goodenow, T.J., Malarkey, W.B., Leukocytosis and artifactual hypoglycemia (1977) JAMA, 237, pp. 1961-1962

Hirshberg, B., Livi, A., Bartlett, D.L., Forty-eight-hourfast: the diagnostic test for insulinoma (2000) J Clin Endocrinol Metab, 85, pp. 3222-3226

Won, J.G., Tseng, H.S., Yang, A.H., Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS) (2006) Clin Endocrinol (Oxf), 65, pp. 566-578

Service, G.J., Thompson, G.B., Service, F.J., Andrews, J.C., Collazo-Clavell, M.L., Lloyd, R.V., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery (2005) N Engl J Med, 353, pp. 249-254

Patti, M.E., McMahon, G., Mun, E.C., Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia (2005) Diabetologia, 48, pp. 2236-2240

Spanakis, E., Gragnoli, C., Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia (2009) Obes Surg, 19, pp. 1333-1334

Taylor, S.I., Barbetti, F., Accili, D., Roth, J., Gorden, P., Syndromes of autoimmunity and hypoglycemia Autoantibodies directed against insulin and its receptor (1989) Endocrinol Metab Clin North Am, 18, pp. 123-143

Arnqvist, H.J., Halban, P.A., Mathiesen, U.L., Zahnd, G., von Schenck, H., Hypoglycaemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy (1993) J Intern Med, 234, pp. 421-427

Halsall, D.J., Mangi, M., Soos, M., Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma (2007) J Clin Endocrinol Metab, 92, pp. 2013-2016

Walters, E.G., Tavaré, J.M., Denton, R.M., Walters, G., Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease (1987) Lancet, 1, pp. 241-243

Frystyk, J., Skjaerbaek, C., Zapf, J., Orskov, H., Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia (1998) Diabetologia, 41, pp. 589-594

Teale, J.D., Marks, V., Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulinlike growth factor I in the diagnosis of non-islet cell tumour hypoglycemia (1990) Clin Endocrinol (Oxf), 33, pp. 87-98

Schwab, S., Spranger, M., Krempien, S., Hacke, W., Bettendorf, M., Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury (1997) Stroke, 28, pp. 1744-1748

Clark, M.A., Hentzen, B.T., Plank, L.D., Hill, G.I., Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury (1996) JPEN J Parenter Enteral Nutr, 20, pp. 363-370

Blum, W., Insulin-like growth factors and their binding proteins Diagnostics of Endocrine Function in Children and Adolescents, 1996, pp. 190-218. , Ranke M, ed. Heidelberg, Germany: Barth Verlag

Daughaday, W.H., Trivedi, B., Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia (1992) J Clin Endocrinol Metab, 75, pp. 110-115

Mason, B.H., Tatnell, M.A., Holdaway, I.M., Measurement of human IGF-II using Sephacryl extraction: a rapid and reliable assay method (1996) Ann Clin Biochem, 33 (3), pp. 201-208

Liu, F., Baker, B.K., Powell, D.R., Hintz, R.L., Characterization of proinsulin-like growth factor-II E-region immunoreactivity in serum and other biological fluids (1993) J Clin Endocrinol Metab, 76, pp. 1095-1100

Tally, M., Eriksson, U., Thorén, M., Brismar, K., Hall, K., Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin (1994) J Clin Endocrinol Metab, 79, pp. 1576-1581

Miraki-Moud, F., Grossman, A.B., Besser, M., Monson, J.P., Camacho-Hübner C. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia (2005) J Clin Endocrinol Metab, 90, pp. 3819-3823

Seckl, M.J., Mulholland, P.J., Bishop, A.E., Teale, J.D., Hales, C.N., Glaser, M., Watkins, S., Seckl, J.R., Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix (1999) NEngl J Med, 341, pp. 733-736

Baker, J., Liu, J.P., Robertson, E.J., Efstratiadis, A., Role of insulin-like growth factors in embryonic and postnatal growth (1993) Cell, 75, pp. 73-82

Stylianopoulou, F., Herbert, J., Soares, M.B., Efstratiadis, A., Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system (1988) Proc Natl Acad Sci U S A, 85, pp. 141-145

Bell, G.I., Gerhard, D.S., Fong, N.M., Sanchez-Pescador, R., Rall, L.B., Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous (1985) Proc Natl Acad Sci U S A, 82, pp. 6450-6454

de Pagter-Holthuizen, P., Jansen, M., van Schaik, F.M., The human insulin-like growth factor II gene contains two development-specific promoters (1987) FEBS Lett, 214, pp. 259-264

Le Roith, D., Seminars in medicine of the Beth Israel Deaconess Medical Center Insulin-like growth factors (1997) NEngl J Med, 336, pp. 633-640

Zapf, J., Walter, H., Froesch, E.R., Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia (1981) J Clin Invest, 68, pp. 1321-1330

Boari, A., Barreca, A., Bestetti, G.E., Minuto, F., Venturoli, M., Hypoglycemia in a dog with a leiomyoma of the gastric wall producing an insulin-like growth factor II-like peptide (1995) Eur J Endocrinol, 132, pp. 744-750

Sussenbach, J.S., Steenbergh, P.H., Holthuizen, P., Structure and expression of the human insulin-like growth factor genes (1992) Growth Regulation, 2, pp. 1-9

Reik, W., Murrell, A., Genomic imprinting Silence across the border (2000) Nature, 405, pp. 408-409

Lighten, A.D., Hardy, K., Winston, R.M., Moore, G.E., IGF2 isparentally imprinted in human preimplantation embryos (1997) Nat Genet, 15, pp. 122-123

Ohlsson, R., Nyström, A., Pfeifer-Ohlsson, S., IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome (1993) Nat Genet, 4, pp. 94-97

Bell, A.C., Felsenfeld, G., Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene (2000) Nature, 405, pp. 482-485

Jelinic, P., Shaw, P., Loss of imprinting and cancer (2007) J Pathol, 211, pp. 261-268

Bertherat, J., Logie, A., Gicquel, C., Mourrieras, F., Luton, J.P., Le Bouc, Y., Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH) (2000) Clin Endocrinol (Oxf), 53, pp. 213-220

Toretsky, J.A., Helman, L.J., Involvement of IGF-II in human cancer (1996) J Endocrinol, 149, pp. 367-372

Hajdu, M., Singer, S., Maki, R.G., Schwartz, G.K., Keohan, M.L., Antonescu, C.R., IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting (2010) J Pathol, 221, pp. 300-307

Fu, V.X., Dobosy, J.R., Desotelle, J.A., Aging and cancerrelated loss of insulin-like growth factor 2 imprinting in the mouse and human prostate (2008) Cancer Res, 68, pp. 6797-6802

Ohta, M., Sugimoto, T., Seto, M., Genetic alterations in colorectal cancers with demethylation of insulin-like growth factor II (2008) Hum Pathol, 39, pp. 1301-1308

Chen, C.L., Ip, S.M., Cheng, D., Wong, L.C., Ngan, H.Y., Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer (2000) Clin Cancer Res, 6, pp. 474-479

Oda, H., Kume, H., Shimizu, Y., Inoue, T., Ishikawa, T., Loss of imprinting of igf2 in renal-cell carcinomas (1998) Int J Cancer, 75, pp. 343-346

Anderson, J., Gordon, A., McManus, A., Shipley, J., Pritchard-Jones, K., Disruption of imprinted genes at chromosome region 11p15 5 in paediatric rhabdomyosarcoma (1999) Neoplasia, 1, pp. 340-348

Monk, D., Sanches, R., Arnaud, P., Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human (2006) Hum Mol Genet, 15, pp. 1259-1269

Wutz, A., Smrzka, O.W., Schweifer, N., Schellander, K., Wagner, E.F., Barlow, D.P., Imprinted expression of the Igf2r gene depends on an intronic CpG island (1997) Nature, 389, pp. 745-749

Van den Brande, J.L., A personal view on the early history of the insulin-like growth factors (1999) Horm Res, 51 (SUPPL. 3), pp. 149-175

van Dijk, E.L., Sussenbach, J.S., Holthuizen, P.E., Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs (2001) Nucleic Acids Res, 29, pp. 3477-3486

Holthuizen, P.E., Cleutjens, C.B., Veenstra, G.J., van der Lee, F.M., Koonen-Reemst, A.M., Sussenbach, J.S., Differential expression of the human, mouse and rat IGF-II genes (1993) Regul Pept, 48, pp. 77-89

Meinsma, D., Scheper, W., Holthuizen, P.E., Van den Brande, J.L., Sussenbach, J.S., Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene (1992) Nucleic Acids Res, 20, pp. 5003-5009

Rastinejad, F., Blau, H.M., Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation (1993) Cell, 72, pp. 903-917

Qiu, Q., Basak, A., Mbikay, M., Tsang, B.K., Gruslin, A., Role of pro-IGF-II processing by proprotein convertase 4 in human placental development (2005) Proc Natl Acad Sci U S A, 102, pp. 11047-11052

Duguay, S.J., Jin, Y., Stein, J., Duguay, A.N., Gardner, P., Steiner, D.F., Post-translational processing of the insulin-like growth factor-2 precursor Analysis of O-glycosylation and endoproteolysis (1998) J Biol Chem, 273, pp. 18443-18451

Daughaday, W.H., Emanuele, M.A., Brooks, M.H., Barbato, A.L., Kapadia, M., Rotwein, P., Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia (1988) NEngl J Med, 319, pp. 1434-1440

Denley, A., Wallace, J.C., Cosgrove, L.J., Forbes, B.E., The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review (2003) Horm Metab Res, 35, pp. 778-785

Adams, T.E., Epa, V.C., Garrett, T.P., Ward, C.W., Structure and function of the type 1 insulin-like growth factor receptor (2000) Cell Mol Life Sci, 57, pp. 1050-1093

Morrione, A., Valentinis, B., Xu, S.Q., Insulin-like growth factor II stimulates cell proliferation through the insulin receptor (1997) Proc Natl Acad Sci U S A, 94, pp. 3777-3782

Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., Vigneri, R., Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease (2009) Endocr Rev, 30, pp. 586-623

Rikhof, B., van der Graaf, W.T., Suurmeijer, A.J., 'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors (2012) Am J Pathol, 181, pp. 303-312

Annunziata, M., Granata, R., Ghigo, E., The IGF system (2011) Acta Diabetol, 48, pp. 1-9

Alvino, C.L., McNeil, K.A., Ong, S.C., A novel approach to identify two distinct receptor binding surfaces of insulinlike growth factor II (2009) J Biol Chem, 284, pp. 7656-7664

Denley, A., Brierley, G.V., Carroll, J.M., Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain (2006) Endocrinology, 147, pp. 1029-1036

LeRoith, D., Werner, H., Beitner-Johnson, D., Roberts Jr., C.T., Molecular and cellular aspects of the insulin-like growth factor I receptor (1995) Endocr Rev, 16, pp. 143-163

Pandini, G., Conte, E., Medico, E., Sciacca, L., Vigneri, R., Belfiore, A., IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding (2004) Ann N Y Acad Sci, 1028, pp. 450-456

Sacco, A., Morcavallo, A., Pandini, G., Vigneri, R., Belfiore, A., Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A (2009) Endocrinology, 150, pp. 3594-3602

Burvin, R., LeRoith, D., Harel, H., Zloczower, M., Marbach, M., Karnieli, E., The effect of acute insulin-like growth factor-II administration on glucose metabolism in the rat (1998) Growth Horm IGF Res, 8, pp. 205-210

Nissley, P., Kiess, W., Sklar, M., The insulin-like growth factorII-mannose 6-phosphate receptor In: LeRoith D, ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton, FL: CRC Press

Nissley, P., Lopaczynski, W., Insulin-like growth factor receptors (1991) Growth Factors, 5, pp. 29-43

Morgan, D.O., Edman, J.C., Standring, D.N., Fried, V.A., Smith, M.C., Roth, R.A., Rutter, W.J., Insulin-like growth factor II receptor as a multifunctional binding protein (1987) Nature, 329, pp. 301-307

Brown, J., Jones, E.Y., Forbes, B.E., Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes (2009) Vitam Horm, 80, pp. 699-719

Ghosh, P., Dahms, N.M., Kornfeld, S., Mannose 6-phosphate receptors: new twists in the tale (2003) Nat Rev Mol Cell Biol, 4, pp. 202-212

Roche, P., Brown, J., Denley, A., Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data (2006) Proteins, 64, pp. 758-768

Kornfeld, S., Structure and function of the mannose 6-phosphate/ insulinlike growth factor II receptors (1992) Annu Rev Biochem, 61, pp. 307-330

El-Shewy, H.M., Lee, M.H., Obeid, L.M., Jaffa, A.A., Luttrell, L.M., The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells (2007) J Biol Chem, 282, pp. 26150-26157

Scott, C.D., Firth, S.M., The role of the M6P/IGF-II receptor in cancer: tumor suppression or garbage disposal? (2004) Horm Metab Res, 36, pp. 261-271

Wagner, S., Greco, F., Hamza, A., Hoda, R.M., Holzhausen, H.J., Fornara, P., Retroperitoneal malignant solitary fibrous tumor of the small pelvis causing recurrent hypoglycemia by secretion of insulin-like growth factor 2 (2009) Eur Urol, 55, pp. 739-742

Okabe, R., Sonobe, M., Bando, T., Date, H., Large solitary fibrous tumor with overexpression of insulin-like growth factor-2 (2010) Interact Cardiovasc Thorac Surg, 11, pp. 688-690

Rumilla, K.M., Erickson, L.A., Service, F.J., Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression (2009) Mod Pathol, 22, pp. 239-245

Hébert, E., Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development (2006) Biosci Rep, 26, pp. 7-17

Firth, S.M., Baxter, R.C., Cellular actions of the insulin-like growth factor binding proteins (2002) Endocr Rev, 23, pp. 824-854

Bond, J.J., Meka, S., Baxter, R.C., Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6 (2000) J Endocrinol, 165, pp. 253-260

Hwa, V., Oh, Y., Rosenfeld, R.G., Insulin-like growth factor binding proteins: a proposed superfamily (1999) Acta Paediatr Suppl, 88, pp. 37-45

Ueki, I., Ooi, G.T., Tremblay, M.L., Hurst, K.R., Bach, L.A., Boisclair, Y.R., Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system (2000) Proc Natl Acad Sci U S A, 97, pp. 6868-6873

Guler, H.P., Zapf, J., Schmid, C., Froesch, E.R., Insulin-like growth factors I and II in healthy man Estimations of halflives and production rates (1989) Acta Endocrinol (Copenh), 121, pp. 753-758

Zapf, J., Insulinlike growth factor binding proteins and tumor hypoglycemia (1995) Trends Endocrinol Metab, 6, pp. 37-42

Rajaram, S., Baylink, D.J., Mohan, S., Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions (1997) Endocr Rev, 18, pp. 801-831

Mohan, S., Baylink, D.J., IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms (2002) J Endocrinol, 175, pp. 19-31

Rosenzweig, S.A., What's new in the IGF-binding proteins? (2004) Growth Horm IGF Res, 14, pp. 329-336

Hamidou, M., Bani-Sadr, F., Kenzi, A., Sagan, C., Grolleau, J.Y., [Hypoglycemia associated with pleural fibromas Study of insulin-like growth factors (IGF) and pathogenic considerations] (2002) Rev Med Interne, 23, pp. 447-453. , (French)

Daughaday, W.H., Free insulin-like growth factor (IGF) in disorders of IGF binding protein 3 complex formation (2004) J Clin Endocrinol Metab, 89, pp. 3-5

Hoekman, K., van Doorn, J., Gloudemans, T., Maassen, J.A., Schuller, A.G., Pinedo, H.M., Hypoglycemia associated with the production of insulin-like growth factor II and insulinlike growth factor binding protein 6 by a hemangiopericytoma (1999) Clin Endocrinol (Oxf), 51, pp. 247-253

Van Doorn, J., Ringeling, A.M., Shmueli, S.S., Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay (1999) Clin Endocrinol (Oxf), 50, pp. 601-609

Brigstock, D.R., The CCN family: a new stimulus package (2003) J Endocrinol, 178, pp. 169-175

Burren, C.P., Wilson, E.M., Hwa, V., Oh, Y., Rosenfeld, R.G., Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/ NovH), an additional member of the IGFBP Superfamily (1999) J Clin Endocrinol Metab, 84, pp. 1096-1103

Kim, H.S., Nagalla, S.R., Oh, Y., Wilson, E., Roberts Jr., C.T., Rosenfeld, R.G., Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as amember of the IGFBP superfamily (1997) Proc Natl Acad SciUSA, 94, pp. 12981-12986

Baxter, R.C., Binoux, M.A., Clemmons, D.R., Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily (1998) Endocrinology, 139, p. 4036

Grotendorst, G.R., Lau, L.F., Perbal, B., CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily (2000) Endocrinology, 141, pp. 2254-2256

Collet, C., Candy, J., How many insulin-like growth factor binding proteins? (1998) Mol Cell Endocrinol, 139, pp. 1-6

Jakob, A., Meyer, U.A., Flury, R., Ziegler, W.H., Labhart, A., Froesch, E.R., The pathogenesis of tumour hypoglycaemia: blocks of hepatic glucose release and of adipose tissue lipolysis (1967) Diabetologia, 3, pp. 506-514

Cherrington, A.D., The role of hepatic insulin receptors in the regulation of glucose production (2005) J Clin Invest, 115, pp. 1136-1139

Puglianiello, A., Cianfarani, S., Central control of glucose homeostasis (2006) Rev Diabet Stud, 3, pp. 54-60

Obici, S., Zhang, B.B., Karkanias, G., Rossetti, L., Hypothalamic insulin signaling is required for inhibition of glucose production (2002) Nat Med, 8, pp. 1376-1382

Denley, A., Cosgrove, L.J., Booker, G.W., Wallace, J.C., Forbes, B.E., Molecular interactions of the IGF system (2005) Cytokine Growth Factor Rev, 16, pp. 421-439

White, M.F., Regulating insulin signaling and β-cell function through IRS proteins (2006) Can J Physiol Pharmacol, 84, pp. 725-737

Alexandrides, T., Moses, A.C., Smith, R.J., Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle (1989) Endocrinology, 124, pp. 1064-1076

Froesch, E.R., Zapf, J., Insulin-like growth factors and insulin: comparative aspects (1985) Diabetologia, 28, pp. 485-493

Froesch, E.R., Schmid, C., Schwander, J., Zapf, J., Actions of insulin-like growth factors (1985) Annu Rev Physiol, 47, pp. 443-467

Mathupala, S.P., Ko, Y.H., Pedersen, P.L., Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria (2006) Oncogene, 25, pp. 4777-4786

Gogvadze, V., Orrenius, S., Zhivotovsky, B., Mitochondria in cancer cells: what is so special about them? (2008) Trends Cell Biol, 18, pp. 165-173

Frohman, L.A., Jansson, J.O., Growth hormone-releasing hormone (1986) Endocr Rev, 7, pp. 223-253

Frohman, L.A., Downs, T.R., Chomczynski, P., Regulation of growth hormone secretion (1992) Front Neuroendocrinol, 13, pp. 344-405

Widmer, U., Zapf, J., Froesch, E.R., Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulinlike growth factor II? (1982) J Clin Endocrinol Metab, 55, pp. 833-839

Yang, C.Q., Zhan, X., Hu, X., Kondepudi, A., Perdue, J.F., The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain (1996) Endocrinology, 137, pp. 2766-2773

Gorden, P., Hendricks, C.M., Kahn, C.R., Megyesi, K., Roth, J., Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors (1981) N Engl J Med, 305, pp. 1452-1455

Binoux, M., Hossenlopp, P., Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph (1988) J Clin Endocrinol Metab, 67, pp. 509-514

Khosravi, J., Diamandi, A., Mistry, J., Krischna, R.G., The high molecular weight insulin-like growth factor-binding protein complex: epitope mapping, immunoassay, and preliminary clinical evaluation (1999) J Clin Endocrinol Metab, 84, pp. 2826-2833

Frystyk, J., Free insulin-like growth factors: measurements and relationships to growth hormone secretion and glucose homeostasis (2004) Growth Horm IGF Res, 14, pp. 337-375

Christofilis, M.A., Remacle-Bonnet, M., Atlan-Gepner, C., Study of serum big-insulin-like growth factor (IGF)-II and IGF binding proteins in two patients with extrapancreatic tumor hypoglycemia, using a combination of Western blotting methods (1998) Eur J Endocrinol, 139, pp. 317-322

Khosla, S., Ballard, F.J., Conover, C.A., Use of site-specific antibodies to characterize the circulating form of big insulinlike growth factor II in patients with hepatitis C-associated osteosclerosis (2002) J Clin Endocrinol Metab, 87, pp. 3867-3870

Khosla, S., Hassoun, A.A., Baker, B.K., Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis Potential insights into increasing bone mass in adults (1998) J Clin Invest, 101, pp. 2165-2173

Teale, J.D., Wark, G., The effectiveness of different treatment options for non-islet cell tumour hypoglycemia (2004) Clin Endocrinol (Oxf), 60, pp. 457-460

Zapf, J., Futo, E., Peter, M., Froesch, E.R., Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? (1992) J Clin Invest, 90, pp. 2574-2584

Papaioannou, A., Tumors other than insulinomas associated with hypoglycemia (1966) Surg Gynecol Obstet, 123, pp. 1093-1109

Howard, J.W., Davis, P.L., Retroperitoneal hemangiopericytoma associated with hypoglycemia and masculinization (1959) Del Med J, 31, pp. 29-34

Fö ger, B., Zapf, J., Lechleitner, M., Konwalinka, G., Patsch, J.R., Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased 'big' insulinlike growth factor II (1994) J Intern Med, 236, pp. 692-693

Kotani, K., Tsuji, M., Oki, A., IGF-II producing hepatic fibrosarcoma associated with hypoglycemia (1993) Intern Med, 32, pp. 897-901

Hunter, S.J., Daughaday, W.H., Callender, M.E., A case of hepatoma associated with hypoglycemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin (1994) Clin Endocrinol (Oxf), 41, pp. 397-401. , discussion 402

Baxter, R.C., Holman, S.R., Corbould, A., Stranks, S., Ho, P.J., Braund, W., Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia (1995) J Clin Endocrinol Metab, 80, pp. 2700-2708

Perros, P., Simpson, J., Innes, J.A., Teale, J.D., McKnight, J.A., Non-islet cell tumour-associated hypoglycemia: 111Inoctreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids (1996) Clin Endocrinol (Oxf), 44, pp. 727-731

Bourcigaux, N., Arnault-Ouary, G., Christol, R., Périn, L., Charbonnel, B., Le Bouc, Y., Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia (2005) Clin Ther, 27, pp. 246-251

Drake, W.M., Miraki, F., Siddiqi, A., Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia (1998) Eur J Endocrinol, 139, pp. 532-536

Holt, R.I., Simpson, H.L., Sö nksen, P.H., The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis (2003) Diabet Med, 20, pp. 3-15

Reubi, J.C., Zimmermann, A., Jonas, S., Regulatory peptide receptors in human hepatocellular carcinomas (1999) Gut, 45, pp. 766-774

Cebon, J., Findlay, M., Hargreaves, C., Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (2006) Br J Cancer, 95, pp. 853-861

Chung, J., Henry, R.R., Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma (1996) J Clin Endocrinol Metab, 81, pp. 919-925

Hoff, A.O., Vassilopoulou-Sellin, R., The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia (1998) Cancer, 82, pp. 1585-1592

Marks, V., Teale, J., Tumours producing hypoglycemia (1998) Endocr Relat Cancer, 5, pp. 111-129

Tolcher, A.W., Sarantopoulos, J., Patnaik, A., Phase I, pharmacokinetic and pharmacodynamic study of AMG 479 a fully human monoclonal antibody to insulin-like growth factor receptor 1 (2009) J Clin Oncol, 27, pp. 5800-5807

Olmos, D., Postel-Vinay, S., Molife, L.R., Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751 871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study (2010) Lancet Oncol, 11, pp. 129-135

Martins, A.S., Mackintosh, C., Martín, D.H., Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor (2006) Clin Cancer Res, 12, pp. 3532-3540

Scotlandi, K., Manara, M.C., Nicoletti, G., Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors (2005) Cancer Res, 65, pp. 3868-3876

Manara, M.C., Landuzzi, L., Nanni, P., Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing's sarcoma (2007) Clin Cancer Res, 13, pp. 1322-1330

Kurzrock, R., Patnaik, A., Aisner, J., A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors (2010) Clin Cancer Res, 16, pp. 2458-2465

Prince, S.N., Foulstone, E.J., Zaccheo, O.J., Williams, C., Hassan, A.B., Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor (2007) Mol Cancer Ther, 6, pp. 607-617

Feng, Y., Zhu, Z., Xiao, X., Choudhry, V., Barrett, J.C., Dimitrov, D.S., Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function (2006) Mol Cancer Ther, 5, pp. 114-120

O'Gorman, D.B., Weiss, J., Hettiaratchi, A., Firth, S.M., Scott, C.D., Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo (2002) Endocrinology, 143, pp. 4287-4294

Ponomarenko, N.A., Durova, O.M., Vorobiev, I.I., Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen (2006) Proc Natl Acad Sci U S A, 103, pp. 281-286

Pravtcheva, D.D., Wise, T.L., Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice (1998) J Exp Zool, 281, pp. 43-57

Friedrichs, N., Kü chler, J., Endl, E., Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma (2008) J Pathol, 216, pp. 428-439

Riedemann, J., Macaulay, V.M., IGF1R signalling and its inhibition (2006) Endocr Relat Cancer, 13 (SUPPL. 1), pp. S33-S43

Avnet, S., Salerno, M., Quacquaruccio, G., Granchi, D., Giunti, A., Baldini, N., IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors (2011) Exp Cell Res, 317, pp. 2147-2158

Yalow, R.S., Berson, S.A., Immunoassay of endogenous plasma insulin in man (1960) J Clin Invest, 39, pp. 1157-1175

Megyesi, K., Kahn, C.R., Roth, J., The NSILA-s receptor in liver plasma membranes Characterization and comparison with the insulin receptor (1975) J Biol Chem, 250, pp. 8990-8996

Megyesi, K., Gorden, P., Kahn, R., Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides (1977) J Clin Endocrinol Metab, 45, pp. 330-338

Hyodo, T., Megyesi, K., Kahn, C.R., McLean, J.P., Friesen, H.G., Adrenocortical carcinoma and hypoglycemia: evidence forproduction of nonsuppressible insulin-like activity by the tumor (1977) J Clin Endocrinol Metab, 44, pp. 1175-1184

Blundell, T., Bedarkar, S., Rinderknecht, E., Humbel, R., Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding (1978) Proc Natl Acad Sci U S A, 75, p. 180

von Mering, J., Minkowski, O., [Diabetes mellitus nach Pankreasextirpation ] (1889) Arch Exp Pathol Pharmakol, 26, pp. 371-387. , (German)

Starling, E.H., The Croonian lectures on the chemical correlation of the functions of the body: delivered before the Royal College of Physicians of London on June 20th, 22nd, 27th, 29th (1905) Lancet, 2, pp. 339-341

Pavy, F.W., Siau, R.L., The influence of ablation of the liver on the sugar contents of the blood (1903) J Physiol, 29, pp. 375-381

Best, C., Epochs in the history of diabetes (1960) Diabetes With a Chapter on Hypoglycemia, p. 5. , Williams RH, ed. NewYork, NY: Paul B. Hoeber

Porges, O., [Über den Einfluss der Nebennieren auf den Kohlehydratstoffwechsel] (1910) Verhandlungen des deutschen Kongresses fuer Innere Medizin, 27, pp. 591-595. , (German)

Kauvar, A., Goldner, M., Historical overview (1954) Hypoglycemia and the Hypoglycemic Syndrome, pp. 3-7. , Springfield, IL: CC Thomas

Joslin, E., Practical lessons for physicians and patients in diabetes (1921) Med Clin N Am, p. 22

Minkowski, O., [Beitrage zur Pathologie der Leber auf den Stoffwechsel III. Ueber den Einfluss der Leberexstirpation auf den Stoffwechsel] (1886) Arch Exp Pathol Pharmakol, 21, p. 41. , (German)

Mann, F.C., Magath, T.B., Studies on physiology of liver II. The effect of removal of liver on blood sugar level (1922) Arch Intern Med, 30, pp. 73-84

Sakel, M., Neue Behandlung der Morphinsucht (1933) Zeitschrift Gesamte Neurol Psychiatr, 143, pp. 506-534

Harris, S., Hyperinsulinism and dysinsulinism (1924) JAMA, 83, p. 729

Wilder, R.M., Allan, F.N., Power, M., Robertson, H., Carcinoma of the islands of the pancreas (1927) JAMA, 89, p. 348

Howland, G., Campbell, W.R., Maltby, E.J., Robinson, W., Dysinsulinism (1929) JAMA, 93, p. 674

Doege, K.W., Fibro-sarcoma of the mediastinum (1930) Ann Surg, 92, pp. 955-960

Baldwin, R.S., Hypoglycemia associated with fibrosarcoma of mediastinum: review of Doege's patient (1964) Ann Surg, 160, pp. 975-977

Anderson, H., A tumor of the adrenal gland with fatal hypoglycemia (1930) Am J Med Sci, 180, p. 71

Conn, J.W., Seltzer, H.S., Spontaneous hypoglycemia (1955) Am J Med, 19, pp. 460-478

Frantz, V.K., Tumors of islet cells with hyperinsulinism

benign, malignant, and questionable (1940) Ann Surg, 112, p. 161

Yalow, R.S., Radioimmunoassay: a probe for fine structure of biological systems Nobel Lectures In Physiology Or Medicine 1971-1980, 1992, pp. 447-468. , Lindsten J, ed. Singapore: World Scientific Publishing

Nissan, S., Bar-Maor, A., Shafrir, E., Hypoglycemia associated with extrapancreatic tumors Two cases with biochemical investigations of glucose and fatty acid metabolism (1968) NEngl J Med, 278, pp. 177-183

Kahn, C.R., The riddle of tumour hypoglycaemia revisited (1980) Clin Endocrinol Metab, 9, pp. 335-360

Unger, R.H., The riddle of tumor hypoglycemia (1966) Am J Med, 40, pp. 325-330

Kreisberg, R.A., Hershman, J.M., Spenney, J.G., Boshell, B.R., Pennington, L.F., Biochemistry of extrapancreatic tumor hypoglycemia (1970) Diabetes, 19, pp. 248-258

Chandalia, H.B., Boshell, B.R., Hypoglycemia associated with extrapancreatic tumors Report of two cases with studies on its pathogenesis (1972) Arch Intern Med, 129, pp. 447-456

Silbert, C.K., Rossini, A.A., Ghazvinian, S., Widrich, W.C., Marks, L.J., Sawin, C.T., Tumor hypoglycemia: deficient splanchnic glucose output and deficient glucagon secretion (1976) Diabetes, 25, pp. 202-206

Lowe Jr., W.L., Roberts Jr., C.T., LeRoith, D., Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid (1989) J Clin Endocrinol Metab, 69, pp. 1153-1159

Furlanetto, R.W., Underwood, L.E., VanWyk, J.J., D'Ercole, A.J., Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay (1977) J Clin Invest, 60, pp. 648-657

Merimee, T.J., Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia (1986) Metabolism, 35, pp. 360-363

Shapiro, E.T., Bell, G.I., Polonsky, K.S., Rubenstein, A.H., Kew, M.C., Tager, H.S., Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II (1990) J Clin Invest, 85, pp. 1672-1679

Laurent, J., Debry, G., Floquet, J., HypoglycemicTumors.Amsterdam The Netherlands: Excerpta Medica Foundation

Eastman, R.C., Kahn, C.R., Hypoglycemia (1996) Diagnostic Endocrinology, pp. 229-242. , Moore WT, Eastman RC, eds. Mosby

Lorenzi, M., Hypoglycemia Handbook of Clinical Endocrinology, 1992, pp. 561-581. , Fitzgerald PA, ed. San Mateo, CA: Appleton 2nd ed. Lange Medical Publications

Banting, F.G., Best, C.H., Collip, J.B., Campbell, W.R., Fletcher, A.A., Macleod, J.J.R., Noble, E.C., The effect produced on didoiabetes by extracts of pancreas (1922) Trans AssocAmPhysicians, 37, pp. 337-347

Snapper, I., van Creveld, S., Un cas d'hypoglycemia avec acétonémia chez un enfant (1928) Bull Mem Soc Med Hop Paris, 52, pp. 1315-1324

El-Shewy, H.M., Luttrell, L.M., Insulin-like growth factor-2/ mannose-6 phosphate receptors (2009) Vitam Horm, 80, pp. 667-697

Palladino, A.A., Stanley, C.A., Nesidioblastosis no longer! It's all about genetics (2011) J Clin Endocrinol Metab, 96, pp. 617-619

Myint, K.S., Greenfield, J.R., Faroogi, I.S., Henning, E., Holst, J.J., Finer, N., Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue (2012) Eur J Endocrinol, 166, pp. 951-955

Krejs, G.J., Non-insulin-secreting tumors of the gastroenteropancreatic system Williams Textbook of Endocrinology, 1998, pp. 1663-1673. , 9th ed.Wilson JD, Foster DW, Larsen PR, KronenbergHeds. W. B. Saunders Company

Graves, R., Hodge, A., (1966) The Reader Over Your Shoulder: A Handbook for Writers of English Prose, p. 17. , Collier Books

Roth, J., Kahn, C.R., Lesniak, M.A., Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man (1975) Recent Prog Horm Res, 31, pp. 95-139

Roth, J., Lesniak, M.A., Bar, R.S., An introduction to receptors and receptor disorders (1979) Proc Soc Exp Biol Med, 162, pp. 3-12

Koch, C. A., Rother, K. I., Roth, J., Tumor hypoglycemia linked to IGF-II. The IGF System: Molecular Biology, Physiology, and Clinical Applications. Totowa, 1999, pp. 675-698. , NJ: Humana Press

Elliot, C. A., Hepatic hypoglycemia associated with primary liver cell carcinoma (1929) Trans AssocAmPhysicians, 44, pp. 121-126

McFadzean, A. J., Yeung, R. T., Further observations on hypoglycaemia in hepatocellular carcinoma (1969) Am J Med, 47, pp. 220-235

Herrmann, B. L., Saller, B., Kiess, W., Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia (2000) Exp Clin Endocrinol Diabetes, 108, pp. 515-518

Baker, J. L., Aleman, M., Madigan, J., Intermittent hypoglycemia in a horse with anaplastic carcinoma of the kidney (2001) J Am Vet Med Assoc, 218, pp. 235-237

Kim, J. H., Kim, J. O., Kim, S. Y., Na, M. H., Lim, S. P., Kim, J. M., Two cases of large solitary fibrous tumors of the pleura associated with fasting hypoglycemia (2001) Eur Radiol, 11, pp. 819-824

Filosso, P. L., Oliaro, A., Rena, O., Papalia, E., Ruffini, E., Mancuso, M., Severe hypoglycaemia associated with a giant solitary fibrous tumor of the pleura (2002) J Cardiovasc Surg (Torino), 43, pp. 559-561

Nanayakkara, P. W., van Doorn, J., van den Berg, F. G., van Groeningen, C. J., Pinedo, H. M., Hoekman, K., Treatment of haemangiopericytoma-associated hypoglycemia with embolisation (2002) Eur J Intern Med, 13, pp. 340-343

Beckers, M. M., Slee, P. H., van Doorn, J., Hypoglycaemia in a patient with a gastrointestinal stromal tumour (2003) Clin Endocrinol (Oxf), 59, pp. 402-404

Stein, R. H., Herman, S. D., Phelps, R. G., Sapadin, A. N., Florid eruption of seborrheic keratoses associated with elevated insulin-like growth factor, hypoglycemia, and solitary fibrous tumor of the pleura (2004) Int J Dermatol, 43, pp. 944-947

Fernando, H. S., Hawkyard, S. J., Poon, P., Musa, M., Renal cell carcinoma with non-islet cell tumor hypoglycemia (2006) Int J Urol, 13, pp. 985-986

Chang, J. C., Su, K. Y., Chao, S. F., Hsu, Y. H., Yang, G. G., Chang, B. S., Hypoglycemia in a patient with a huge malignant solitary fibrous tumor of the pleura (2007) Pathol Int, 57, pp. 791-793

de Groot, J. W., Rikhof, B., van Doorn, J., Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases (2007) Endocr Relat Cancer, 14, pp. 979-993

Escobar, G. A., Robinson, W. A., Nydam, T. L., Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report (2007) BMC Cancer, 7, p. 13

Nauck, M. A., Reinecke, M., Perren, A., Hypoglycemia due to paraneoplastic secretion of insulin-like growth fac-tor-I in a patient with metastasizing large-cell carcinoma of the lung (2007) J Clin Endocrinol Metab, 92, pp. 1600-1605

Chung, J. O., Hong, S. I., Cho, D. H., Lee, J. H., Chung, D. J., Chung, M. Y., Hypoglycemia associated with the production of insulin-like growth factor II in a pancreatic islet cell tumor: a case report (2008) Endocr J, 55, pp. 607-612

Hall, K. F., Lin, C. L., Wang, T. H., Chang, R. H., Chen, H. M., A case of gastrointestinal stromal tumor with hyperinsulinemic hypoglycemia (2008) Chang Gung Med J, 31, pp. 107-111

Marks, V., Rose, F. C., Extra-pancreatic neoplasms, 1981, pp. 246-266. , Hypoglycemia. Oxford, UK: Blackwell Scientific PublicationsBriselli, M., Mark, E. J., Dickersin, G. R., Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature (1981) Cancer, 47, pp. 2678-2689

England, D. M., Hochholzer, L., McCarthy, M. J., Localized benign and malignant fibrous tumors of the pleura A clinicopathologic review of 223 cases (1989) AmJ Surg Pathol, 13, pp. 640-658

Mayou, S. C., Benn, J. J., Sonksen, P. H., Black, M. M., Paraneoplastic rhinophyma and the Leser-Tr lat sign (1989) Clin Exp Dermatol, 14, pp. 253-255

Lawson, E. A., Zhang, X., Crocker, J. T., Wang, W. L., Klibanski, A., Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma (2009) J Clin Endocrinol Metab, 94, pp. 2226-2231

Dizon, A. M., Kowalyk, S., Hoogwerf, B. J., Neuroglycopenic and other symptoms in patients with insulinomas (1999) Am J Med, 106, pp. 307-310

Crocker, D. W., Veith, F. J., Mesodermal tumors associated with hypoglycemia: review of literature and report of a case (1965) Ann Surg, 161, pp. 418-427

Deary, I. J., Symptoms of hypoglycaemia and effects on mental performance and emotions Hypoglycaemia in Clinical Diabetes, 2007, pp. 25-48. , Frier BM, Fisher M, eds New York, NY: Wiley

Cryer, P. E., Hypoglycemia, functional brain failure, and brain death (2007) J Clin Invest, 117, pp. 868-870

Amiel, S. A., Sherwin, R. S., Simonson, D. C., Tamborlane, W. V., Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release (1988) Diabetes, 37, pp. 901-907

Boyle, P. J., Schwartz, N. S., Shah, S. D., Clutter, W. E., Cryer, P. E., Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics (1988) NEngl J Med, 318, pp. 1487-1492

Cryer, P. E., Axelrod, L., Grossman, A. B., Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline (2009) J Clin Endocrinol Metab, 94, pp. 709-728

Cahill Jr., G. F., Herrera, M. G., Morgan, A. P., Hormonefuel interrelationships during fasting (1966) J Clin Invest, 45, pp. 1751-1769

Stanley, C. A., Baker, L., Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia (1976) Pediatrics, 57, pp. 702-711

Eastman, R. C., Carson, R. E., Orloff, D. G., Glucose utilization in a patient with hepatoma and hypoglycemia Assessment by a positron emission tomography (1992) J Clin Invest, 89, pp. 1958-1963

M ller, N., Blum, W. F., Mengel, A., Hansen, L. B., Alberti, K. G., Schmitz, O., Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia

Fehmann, H. C., Jehle, P., Markus, U., G ke, B., Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells (1996) Metabolism, 45, pp. 759-766

Thakker, R. V., Multiple endocrine neoplasia type 1. Principles of Molecular Medicine. Totowa, 2006, pp. 386-392. , NJ: Humana Press

Service, F. J., Factitial hypoglycemia (1992) Endocrinologist, 2, pp. 173-176

Lebowitz, M. R., Blumenthal, S. A., The molar ratio of insulin to C-peptide An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration (1993) Arch Intern Med, 153, pp. 650-655

Whipple, A. O., The surgical therapy of hyperinsulinism (1938) J Int Chir, 3, pp. 237-276

Whipple, A. O., Present-day surgery of the pancreas (1942) N Engl J Med, 226, pp. 515-526

Astles, J. R., Petros, W. P., Peters, W. P., Sedor, F. A., Artifactual hypoglycemia associated with hematopoietic cytokines (1995) Arch Pathol Lab Med, 119, pp. 713-716

Goodenow, T. J., Malarkey, W. B., Leukocytosis and artifactual hypoglycemia (1977) JAMA, 237, pp. 1961-1962

Won, J. G., Tseng, H. S., Yang, A. H., Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS) (2006) Clin Endocrinol (Oxf), 65, pp. 566-578

Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., Lloyd, R. V., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery (2005) N Engl J Med, 353, pp. 249-254

Patti, M. E., McMahon, G., Mun, E. C., Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia (2005) Diabetologia, 48, pp. 2236-2240

Taylor, S. I., Barbetti, F., Accili, D., Roth, J., Gorden, P., Syndromes of autoimmunity and hypoglycemia Autoantibodies directed against insulin and its receptor (1989) Endocrinol Metab Clin North Am, 18, pp. 123-143

Arnqvist, H. J., Halban, P. A., Mathiesen, U. L., Zahnd, G., von Schenck, H., Hypoglycaemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy (1993) J Intern Med, 234, pp. 421-427

Halsall, D. J., Mangi, M., Soos, M., Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma (2007) J Clin Endocrinol Metab, 92, pp. 2013-2016

Walters, E. G., Tavar, J. M., Denton, R. M., Walters, G., Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease (1987) Lancet, 1, pp. 241-243

Teale, J. D., Marks, V., Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulinlike growth factor I in the diagnosis of non-islet cell tumour hypoglycemia (1990) Clin Endocrinol (Oxf), 33, pp. 87-98

Clark, M. A., Hentzen, B. T., Plank, L. D., Hill, G. I., Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury (1996) JPEN J Parenter Enteral Nutr, 20, pp. 363-370

Daughaday, W. H., Trivedi, B., Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia (1992) J Clin Endocrinol Metab, 75, pp. 110-115

Mason, B. H., Tatnell, M. A., Holdaway, I. M., Measurement of human IGF-II using Sephacryl extraction: a rapid and reliable assay method (1996) Ann Clin Biochem, 33 (3), pp. 201-208

Liu, F., Baker, B. K., Powell, D. R., Hintz, R. L., Characterization of proinsulin-like growth factor-II E-region immunoreactivity in serum and other biological fluids (1993) J Clin Endocrinol Metab, 76, pp. 1095-1100

Seckl, M. J., Mulholland, P. J., Bishop, A. E., Teale, J. D., Hales, C. N., Glaser, M., Watkins, S., Seckl, J. R., Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix (1999) NEngl J Med, 341, pp. 733-736

Baker, J., Liu, J. P., Robertson, E. J., Efstratiadis, A., Role of insulin-like growth factors in embryonic and postnatal growth (1993) Cell, 75, pp. 73-82

Bell, G. I., Gerhard, D. S., Fong, N. M., Sanchez-Pescador, R., Rall, L. B., Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous (1985) Proc Natl Acad Sci U S A, 82, pp. 6450-6454

Sussenbach, J. S., Steenbergh, P. H., Holthuizen, P., Structure and expression of the human insulin-like growth factor genes (1992) Growth Regulation, 2, pp. 1-9

Lighten, A. D., Hardy, K., Winston, R. M., Moore, G. E., IGF2 isparentally imprinted in human preimplantation embryos (1997) Nat Genet, 15, pp. 122-123

Ohlsson, R., Nystr m, A., Pfeifer-Ohlsson, S., IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome (1993) Nat Genet, 4, pp. 94-97

Bell, A. C., Felsenfeld, G., Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene (2000) Nature, 405, pp. 482-485

Toretsky, J. A., Helman, L. J., Involvement of IGF-II in human cancer (1996) J Endocrinol, 149, pp. 367-372

Fu, V. X., Dobosy, J. R., Desotelle, J. A., Aging and cancerrelated loss of insulin-like growth factor 2 imprinting in the mouse and human prostate (2008) Cancer Res, 68, pp. 6797-6802

Chen, C. L., Ip, S. M., Cheng, D., Wong, L. C., Ngan, H. Y., Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer (2000) Clin Cancer Res, 6, pp. 474-479

Van den Brande, J. L., A personal view on the early history of the insulin-like growth factors (1999) Horm Res, 51 (SUPPL. 3), pp. 149-175

van Dijk, E. L., Sussenbach, J. S., Holthuizen, P. E., Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs (2001) Nucleic Acids Res, 29, pp. 3477-3486

Holthuizen, P. E., Cleutjens, C. B., Veenstra, G. J., van der Lee, F. M., Koonen-Reemst, A. M., Sussenbach, J. S., Differential expression of the human, mouse and rat IGF-II genes (1993) Regul Pept, 48, pp. 77-89

Duguay, S. J., Jin, Y., Stein, J., Duguay, A. N., Gardner, P., Steiner, D. F., Post-translational processing of the insulin-like growth factor-2 precursor Analysis of O-glycosylation and endoproteolysis (1998) J Biol Chem, 273, pp. 18443-18451

Daughaday, W. H., Emanuele, M. A., Brooks, M. H., Barbato, A. L., Kapadia, M., Rotwein, P., Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia (1988) NEngl J Med, 319, pp. 1434-1440

Adams, T. E., Epa, V. C., Garrett, T. P., Ward, C. W., Structure and function of the type 1 insulin-like growth factor receptor (2000) Cell Mol Life Sci, 57, pp. 1050-1093

Alvino, C. L., McNeil, K. A., Ong, S. C., A novel approach to identify two distinct receptor binding surfaces of insuli



Tumors of mesenchymal and epithelial origin produce IGF-2, which activates pathways in the tumors. In a minority of patients, the tumors (hepatomas, fibromas, and fibrosarcomas are the most common among many) release into the circulation enough IGF-2-related peptides to mimic the fasting hypoglycemia characteristic of patients with insulin-producing islet-cell tumors. Rarely, markedly elevated IGF-2 levels produce somatic changes suggestive of acromegaly. Typically, the elevated IGF-2 levels are associated with suppressed plasma levels of insulin, IGF-1, and GH. Complicating the pathophysiology are the IGF binding proteins (IGFBPs) that can bind IGF-2 and IGF-1, modifying hormone metabolism and action. IGFBP concentrations are often altered in the presence of these tumors. At the cellular level, the 3 hormone-related ligands, IGF-2, IGF-1, and insulin, all bind to 4 (or more) types of IGF-1 receptor (IGF-1R) and insulin receptor (IR). Each receptor has its own characteristic affinity for each ligand, a tyrosine kinase, and overlapping profiles of action in the target cells. The IGF-2R, in addition to binding mannose-6-phosphate-containing proteins, provides an IGF-2 degradation pathway. Recent evidence suggests IGF-2R involvement also in signal transduction. Surgery, the treatment of choice, can produce a cure. For patients not cured by surgery, multiple therapies exist, for the tumor and for hypoglycemia. Potential future therapeutic approaches are sketched. From 1910 to 1930, hypoglycemia, insulin, insulinomas, and non-islet-cell tumors were recognized. The latter third of the century witnessed the emergence of the immunoassay for insulin; the IGFs, their binding proteins, and assays to measure them; and receptors for the insulin-related peptides as well as the intracellular pathways beyond the receptor. In closing, we replace non-islet-cell tumor hypoglycemia, an outdated and misleading label, with IGF-2-oma, self-explanatory and consistent with names of other hormone-secreting tumors.
    Clinical Oncology
Nessun risultato.

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (44 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli    Esporta in BibTeX    Esporta in EndNote

Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (29 visite)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L
* Combined HAT/EZH2 modulation leads to cancer-selective cell death (47 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giordano GM, Stanziano M, Papa M, Mucci A, Prinster A, Soricelli A, Galderisi S
* Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study (56 visite)
European Neuropsychopharmacology (ISSN: 0924-977x), 2018 Apr; 28(5): 589-602.
Impact Factor: 4.239
Dettagli    Esporta in BibTeX    Esporta in EndNote

Brancaccio D, Diana D, Di Maro S, Di Leva FS, Tomassi S, Fattorusso R, Russo L, Scala S, Trotta AM, Portella L, Novellino E, Marinelli L, Carotenuto A
* Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells (3 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2018; 61(7): 2910-2923.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Comegna D, Zannetti A, Del Gatto A, De Paola I, Russo L, Di Gaetano S, Liguoro A, Capasso D, Saviano M, Zaccaro L
* Chemical Modification for Proteolytic Stabilization of the Selective alphavbeta3 Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells (331 visite) (PDF 81 visite)
J Med Chem (ISSN: 1520-4804electronic, 0022-2623linking, 0022-2623print), 2017 Dec 14; 60(23): 9874-9884.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R, Squeglia F, Ruggiero A
* Editorial: Molecular Scenarios Behind Infectious Diseases (87 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2017 Nov 24; 24(36): 3939-3941.
Impact Factor: 3.249
Dettagli    Esporta in BibTeX    Esporta in EndNote

Roviello GN, Iannitti R, Roviello V, Palumbo R, Simonyan H, Vicidomini C
* Synthesis and biological evaluation of a novel Amadori compound (103 visite)
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2017 Nov; 49(2): 327-335.
Impact Factor: 3.196
Dettagli    Esporta in BibTeX    Esporta in EndNote

Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
* Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents (56 visite)
Metallomics (ISSN: 1756-591xelectronic, 1756-5901linking), 2017 Oct 18; 9(10): 1439-1446.
Impact Factor: 4.099
Dettagli    Esporta in BibTeX    Esporta in EndNote

Platella C, Guida S, Bonmassar L, Aquino A, Bonmassar E, Ravagnan G, Montesarchio D, Roviello GN, Musumeci D, Fuggetta MP
* Antitumour activity of resveratrol on human melanoma cells: a possible mechanism related to its interaction with malignant cell telomerase (92 visite)
Biochim Biophys Acta (ISSN: 0006-3002print, 0006-3002linking, 0005-2728), 2017 Aug 02; 1861(11PtA): 2843-2851.
Impact Factor: 4.9
Dettagli    Esporta in BibTeX    Esporta in EndNote

Picone D, Donnarumma F, Ferraro G, Gotte G, Fagagnini A, Butera G, Donadelli M, Merlino A
* A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin (60 visite)
J Chem Res (ISSN: 1873-3344electronic, 0162-0134linking, 0162-0134print), 2017 Aug; 173: 105-112.
Impact Factor: 3.317
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (63 visite)
Eur J Radiol (ISSN: 0720-048x), 2017 Aug; 93: 107-113.
Impact Factor: 2.462
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tomasello MF, Nardon C, Lanza V, Di Natale G, Pettenuzzo N, Salmaso S, Milardi D, Caliceti P, Pappalardo G, Fregona D
* New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway (103 visite)
Eur J Med Chem (ISSN: 1768-3254electronic, 0223-5234linking), 2017 Jun 19; 138: 115-127.
Impact Factor: 4.519
Dettagli    Esporta in BibTeX    Esporta in EndNote

Roviello GN, Iannitti R, Palumbo R, Simonyan H, Vicidomini C, Roviello V
* Lac-L-TTA, a novel lactose-based amino acid-sugar conjugate for anti-metastatic applications (73 visite)
Amino Acids (ISSN: 1438-2199electronic, 0939-4451linking), 2017 May 06; 49(8): 1347-1353.
Impact Factor: 3.173
Dettagli    Esporta in BibTeX    Esporta in EndNote

Platella C, Riccardi C, Montesarchio D, Roviello GN, Musumeci D
* G-quadruplex-based aptamers against protein targets in therapy and diagnostics (80 visite)
Biochimica Et Biophysica Acta (ISSN: 0304-4165linking), 2017 May; 1861(5PtB): 1429-1447.
Impact Factor: 5.083
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (56 visite)
Chembiochem (ISSN: 1439-7633electronic, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 3.322
Dettagli    Esporta in BibTeX    Esporta in EndNote

Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (60 visite)
Cancer Imaging (ISSN: 1470-7330electronic, 1470-7330linking), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 1.286
Dettagli    Esporta in BibTeX    Esporta in EndNote

Filippi M, Catanzaro V, Patrucco D, Botta M, Tei L, Terreno E
* First in vivo MRI study on theranostic dendrimersomes (45 visite)
J Control Release (ISSN: 1873-4995electronic, 0168-3659linking), 2017 Feb 28; 248: 45-52.
Impact Factor: 7.441
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Sacca F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V
* Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon beta-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis (75 visite)
Eur J Neurol (ISSN: 1468-1331electronic, 1351-5101linking), 2017 Feb; 24(2): 446-449.
Impact Factor: 3.988
Dettagli    Esporta in BibTeX    Esporta in EndNote

Martínez-fernández L, Granucci G, Pollum M, Crespo-hernández CE, Persico M, Corral I
* Decoding the Molecular Basis for the Population Mechanism of the Triplet Phototoxic Precursors in UVA Light-Activated Pyrimidine Anticancer Drugs (3 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2017; 23(11): 2619-2627.
Impact Factor: 5.476
Dettagli    Esporta in BibTeX    Esporta in EndNote

Musumeci D, Platella C, Riccardi C, Moccia F, Montesarchio D
* Fluorescence sensing using DNA Aptamers in cancer research and clinical diagnostics (3 visite)
Cancers (ISSN: 2072-6694, 2072-6694linking), 2017; 9(12): N/D-N/D.
Impact Factor: 5.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vigneri R, Goldfine ID, Frittitta L
* Insulin, insulin receptors, and cancer (60 visite)
J Endocrinol Invest (ISSN: 1720-8386electronic, 0391-4097linking), 2016 Dec; 39(12): 1365-1376.
Impact Factor: 2.633
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pisani A, Sabbatini M, Imbriaco M, Riccio E, Rubis N, Prinster A, Perna A, Liuzzi R, Spinelli L, Santangelo M, Remuzzi G, Ruggenenti P
* Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease (84 visite)
Clin Gastroenterol Hepatol (ISSN: 1542-7714electronic, 1542-3565linking), 2016 Feb 1; N/D: N/D-N/D.
Impact Factor: 7.398
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca  S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S
* Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma (158 visite)
Ann Nucl Med (ISSN: 1864-6433electronic, 0914-7187linking), 2016 Jan 11; 30(3): 1-8.
Impact Factor: 1.396
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (176 visite)
Front Cell Neurosci (ISSN: 1662-5102electronic, 1662-5102linking), 2015 Aug 7; 9(AUGUST): 297-297.
Impact Factor: 4.609
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calce E, Monfregola L, Saviano M, De Luca S
* HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor (265 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2015 May 20; 22(21): 2525-2538.
Impact Factor: 3.455
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT,  De Simone G
* DPP-4 inhibitors: a patent review (2012 - 2014) (108 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1354-3776, 1744-7674electronic, 1354-3776linking), 2015 Feb; 25(2): 209-236.
Impact Factor: 4.626
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Del Giudice C, Bertamino A, Ciccarelli M, Gomez-Monterrey I, Campiglia P, Novellino E, Illario M, Trimarco B, De Luca N, Iaccarino G
* New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 (117 visite)
Br J Cancer (ISSN: 0007-0920, 1532-1827electronic, 0007-0920print), 2015 Jan 6; 112(1): 77-85.
Impact Factor: 5.569
Dettagli    Esporta in BibTeX    Esporta in EndNote

Yousif AM, Minopoli M, Bifulco K, Ingangi V, Di Carluccio G, Merlino F, Motti ML, Grieco P, Carriero MV
* Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes (143 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015; 10(5): N/D-N/D.
Impact Factor: 3.057
Dettagli    Esporta in BibTeX    Esporta in EndNote

Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (140 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2015; 91: 1-3.
Impact Factor: 3.902
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mercurio FA, Di Natale C, Pirone L, Scognamiglio PL, Marasco D, Pedone EM, Saviano M, Leone M
* Peptide Fragments of Odin-Sam1: Conformational Analysis and Interaction Studies with EphA2-Sam (153 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2015; 16(11): 1629-1636.
Impact Factor: 2.85
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Severino R, Faggiano A, Masone S, Mansueto G, Maurea S, Fonti R, Salvatore M
* Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma (127 visite)
World J Radiol (ISSN: 1949-8470, 1949-8470electronic, 1949-8470linking), 2014 Oct 28; 6(10): 840-845.
Impact Factor: 0.567
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Franzoso G
* Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta/MKK7 inhibitors (225 visite)
Cancer Cell (ISSN: 1878-3686, 1535-6108), 2014 Oct 13; 26(4): 495-508.
Impact Factor: 23.523
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ringhieri P, Iannitti R, Nardon C, Palumbo R, Fregona D, Morelli G, Accardo A
* Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (140 visite)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2014 Oct 1; 473(1-2): 194-202.
Impact Factor: 3.65
Dettagli    Esporta in BibTeX    Esporta in EndNote

Capasso D, De Paola I, Liguoro A, Del Gatto A, Di Gaetano S, Guarnieri D, Saviano M, Zaccaro L
* Rgdechi-Hcit: Alpha V Beta 3 Selective Pro-Apoptotic Peptide As Potential Carrier For Drug Delivery Into Melanoma Metastatic Cells (130 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Sep 23; 9(9): e106441-e106441.
Impact Factor: 3.234
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (185 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2014 Sep 15; 20(18): 4806-4815.
Impact Factor: 8.722
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messori L, Cinellu MA, Merlino A
* Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c) (124 visite)
Acs Med Chem Lett (ISSN: 1948-5875, 1948-5875print, 1948-5875linking), 2014 Jul 31; 5(10): 1110-1113.
Impact Factor: 3.12
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (126 visite)
Journal Of Bone And Mineral Metabolism (ISSN: 1435-5604, 0914-8779, 0914-8779linking), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ramundo V, Del Prete M, Marotta V, Marciello F, Camera L, Napolitano V,  de LucaL, Circelli L, Colantuoni V, Di Sarno A, Carratu AC, Di Roseto CDL, Colao A, Faggiano A
* Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours (160 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2014 Jun; 80(6): 850-855.
Impact Factor: 3.457
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (112 visite)
European Journal Of Haematology (ISSN: 0902-4441, 0902-4441linking), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cella L, Liuzzi R, D'Avino V, Conson M, Di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R
* Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury (121 visite)
Acta Oncol Acta Oncologica (ISSN: 0284-186x, 1651-226x), 2014 May; 53(5): 613-619.
Impact Factor: 2.997
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D
* Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs (199 visite)
Int J Nanomed (ISSN: 1176-9114, 1178-2013, 1178-2013electronic), 2014 Mar 27; 9(1): 1537-1557.
Impact Factor: 4.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M
* Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (355 visite)
Applied Microbiology And Biotechnology (ISSN: 0175-7598), 2014 Mar; 98(5): 1951-1961.
Impact Factor: 3.337
Dettagli    Esporta in BibTeX    Esporta in EndNote

Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani BM, Parsons SJ, De Placido S, Bianco R
* Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models (142 visite)
Breast Cancer Res Biomed Central Ltd (ISSN: 1465-5411), 2014; 16(3): R45-R45.
Impact Factor: 0.635
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quarantelli M, Palladino O, Prinster A, Schiavone V, Carotenuto B, Brunetti A, Marsili A, Casiello M, Muscettola G, Salvatore M, De Bartolomeis A
* Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia (111 visite)
Biomed Res Int (ISSN: 2314-6141, 2314-6133, 2314-6141electronic), 2014; 2014: 325052-325052.
Impact Factor: 1.579
Dettagli    Esporta in BibTeX    Esporta in EndNote

Milardi D, Sciacca MF, Randazzo L, Raudino A, La Rosa C
* The role of calcium, lipid membranes and islet amyloid polypeptide in the onset of type 2 diabetes: Innocent bystanders or partners in a crime? (143 visite)
Front Endocrinol (ISSN: 1664-2392, 1664-2392linking, 1664-2392print), 2014; 5(DEC): 216-216.
Impact Factor: 3.675
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bergamo P, Cocca E, Palumbo R, Gogliettino M, Rossi M, Palmieri G
* RedOx status, proteasome and APEH: Insights into anticancer mechanisms of t10, c12-conjugated linoleic acid isomer on A375 melanoma cells (144 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013 Nov 19; 8(11): N/D-N/D.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY
* Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (181 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2013 Nov 14; 56(21): 8512-8520.
Impact Factor: 5.48
Dettagli    Esporta in BibTeX    Esporta in EndNote

Severino V, Alessio N, Farina A, Sandomenico A, Cipollaro M, Peluso G, Galderisi U, Chambery A
* Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells (161 visite)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2013 Nov 7; 4(11): e911-e911.
Impact Factor: 5.177
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vergara A, Russo Krauss I, Montesarchio D, Paduano L, Merlino A
* Investigating the Ruthenium Metalation of Proteins: X-ray Structure and Raman Microspectroscopy of the Complex between RNase A and AziRu (97 visite)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2013 Oct 7; 52(19): 10714-10716.
Impact Factor: 4.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

 De Luca S, Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S
* 18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma (111 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pellerito O, Prinzivalli C, Foresti E, Sabatino P, Abbate M, Casella G, Fiore T, Scopelliti M, Pellerito C, Giuliano M, Grasso G, Pellerito L
* Synthesis, chemical characterization and biological activity of new histone acetylation/deacetylation specific inhibitors: A novel and potential approach to cancer therapy (147 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2013 Sep; 125: 16-25.
Impact Factor: 3.274
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT, De Simone G
* Anticancer carbonic anhydrase inhibitors: A patent review (2008-2013) (146 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1354-3776, 1744-7674electronic), 2013 Jun; 23(6): 737-749.
Impact Factor: 3.441
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (195 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vergara A, D’Errico G, Montesarchio D, Mangiapia G, Paduano L, Merlino A
* Interaction of Anticancer Ruthenium Compounds with Proteins: High-Resolution X-ray Structures and Raman Microscopy Studies of the Adduct between Hen Egg White Lysozyme and AziRu (116 visite)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2013 Apr 15; 52(8): 4157-4159.
Impact Factor: 4.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Mangiapia G, Paduano L, Morelli G, Tesauro D
* Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery (159 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Apr; 19(4): 190-197.
Impact Factor: 1.862
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pisano M, De Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C
* In vitro activity of the alphavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells (111 visite)
Anticancer Res (ISSN: 0250-7005, 0250-0700, 1791-7530electronic), 2013 Mar; 33(3): 871-879.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quarantelli M, Giardino G, Prinster A, Aloj G, Carotenuto B, Cirillo E, Marsili A, Salvatore E, Del Giudice E, Pignata C
* Steroid Treatment In Ataxia-Telangiectasia Induces Alterations Of Functional Magnetic Resonance Imaging During Prono-Supination Task (116 visite)
Eur J Paediatr Neurol (ISSN: 1532-2130, 1090-3798, 1532-2130electronic), 2013 Mar; 17(2): 135-140.
Impact Factor: 2
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A
* The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin (121 visite)
European Journal Of Cancer (ISSN: 0959-8049), 2013 Mar; 49(5): 1142-1151.
Impact Factor: 4.819
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (145 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S
* Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors (118 visite)
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.
Impact Factor: 2.857
Dettagli    Esporta in BibTeX    Esporta in EndNote

Costa B, Bendinelli S, Gabelloni P, Da Pozzo E,  Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C
* Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor (108 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013; 8(8): e72281-e72281.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messori L, Scaletti F, Massai L, Cinellu MA, Gabbiani C, Vergara A, Merlino A
* The mode of action of anticancer gold-based drugs: a structural perspective (108 visite)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2013; 49(86): 10100-10102.
Impact Factor: 6.718
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A
* Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (151 visite)
Mol Neurobiol (ISSN: 0893-7648), 2012 Dec; 46(3): 605-613.
Impact Factor: 5.471
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R
* Learning from pathogens: Exploiting host-pathogen liaison for therapeutic development (127 visite)
Curr Protein Pept Sci (ISSN: 1389-2037), 2012 Dec; 13(8): 697-698.
Impact Factor: 2.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lamagna B, Greco A, Guardascione A, Navas L, Ragozzino M, Paciello O, Brunetti A, Meomartino L
* Canine Lipomas Treated with Steroid Injections: Clinical Findings (152 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2012 Nov 30; 7(11): N/D-N/D.
Impact Factor: 3.73
Dettagli    Esporta in BibTeX    Esporta in EndNote

 De Luca S, Palmieri G, Fonti R, Federico P, Del Prete G, Pacelli R, Pace L, Salvatore M, Del Vecchio S
* Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors (102 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, Nevolo MT, Fedele M, Greco A, Greco M, Brunetti G, Fusco A, Foti D, Brunetti A
* The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake (160 visite)
Molecular Endocrinology (ISSN: 0888-8809, 1944-9917electronic), 2012 Sep; 26(9): 1578-1589.
Impact Factor: 4.746
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro AM, Lo Giudice MC, D'Urso A, Lauceri R, Purrello R, Milardi D
* Cationic porphyrins are reversible proteasome inhibitors (154 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2012 Jun 27; 134(25): 10451-10457.
Impact Factor: 10.677
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sciacca MF, Chillemi R, Sciuto S, Pappalardo M, La Rosa C, Grasso D, Milardi D
* Interactions of two O-phosphorylresveratrol derivatives with model membranes (86 visite)
Arch Biochem Biophys (ISSN: 1096-0384, 0003-3986), 2012 May; 521(1-2): 111-116.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer (237 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer (174 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (185 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
Dettagli    Esporta in BibTeX    Esporta in EndNote

Saccà F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G, Carotenuto B, Marsili A, Palma V, De Michele G, Brunetti A, Brescia Morra V, Filla A, Salvatore M
* A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (127 visite)
J Neurol (ISSN: 1432-1459, 0340-5354, 1432-1459electronic), 2012 Jan; 259(1): 132-138.
Impact Factor: 3.578
Dettagli    Esporta in BibTeX    Esporta in EndNote

Folgiero V, Di Carlo SE, Bossi G, Spugnini E, Di Benedetto A, Bon G, Milella M, Fabi A, Accardo A, Morelli G, Mottolese M, Falcioni R
* Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells (131 visite)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2012; 3(12): N/D-N/D.
Impact Factor: 6.044
Dettagli    Esporta in BibTeX    Esporta in EndNote

Castellano I, Merlino A
* γ-glutamyltranspeptidases: Sequence, structure, biochemical properties, and biotechnological applications (108 visite)
Cell Mol Life Sci (ISSN: 1420-682x), 2012; 69(20): 3381-3394.
Impact Factor: 5.615
Dettagli    Esporta in BibTeX    Esporta in EndNote

Faggiano A, Ramundo V, Del Prete M, Marotta V, Marciello F, Camera L, Napolitano V,  de LucaL, Lombardi G, Colao A
* Long-Acting Somatostatin Analogues are Highly Effective in Patients with Early Stage MEN-1-Related Well-Differentiated Neuroendocrine Tumors (82 visite)
Neuroendocrinology (ISSN: 0028-3835), 2012; 96: N/D-N/D.
Impact Factor: 3.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Salsano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Tesauro D, Aloj L, De Rosa G, Morelli G
* Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: A potential theranostic agent (146 visite)
Int J Nanomed (ISSN: 1176-9114, 1178-2013, 1178-2013electronic), 2012; 7: 2007-2017.
Impact Factor: 3.463
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Errico G, Ercole C, Lista M, Pizzo E, Falanga A, Galdiero S, Spadaccini R, Picone D
* Enforcing the positive charge of N-termini enhances membrane interaction and antitumor activity of bovine seminal ribonuclease (105 visite)
Biochim Biophys Acta (ISSN: 0005-2736, 0006-3002, 0925-4439), 2011 Dec; 1808(12): 3007-3015.
Impact Factor: 3.99
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Gasperi M, Prinster A, Vacca G, Pivonello C, Orefice G, Colao A, Morra VB
* Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients (118 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2011 Dec; 18(12): 1402-1406.
Impact Factor: 3.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Adinolfi M, Capasso D, Di Gaetano S, Iadonisi A, Leone L, Pastore A
* A straightforward synthetic access to symmetrical glycosyl disulfides and biological evaluation thereof (110 visite)
Org Biomol Chem (ISSN: 1477-0520, 1477-0539, 1477-0539electronic), 2011 Sep 21; 9(18): 6278-6283.
Impact Factor: 3.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

Falciani C, Accardo A, Brunetti J, Tesauro D, Lelli B, Pini A, Bracci L, Morelli G
* Target-Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides (174 visite)
Chemmedchem (ISSN: 1860-7179, 1860-7187, 1860-7187electronic), 2011 Apr 4; 6(4): 678-685.
Impact Factor: 3.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
* A novel ErbB2 epitope targeted by human antitumor immunoagents (122 visite)
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.
Impact Factor: 3.79
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, Arena G, Fattorusso R, Isernia C, La Mendola D, Malgieri G, Nicoletti VG, Rizzarelli E
* The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor (124 visite)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2011 Mar 21; 17(13): 3726-3738.
Impact Factor: 5.925
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Morisco A, Gianolio E, Tesauro D, Mangiapia G, Radulescu A, Brandt A, Morelli G
* Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications (185 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2011 Feb; 17(2): 154-162.
Impact Factor: 1.799
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pace L, Salvatore M
* Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90 (162 visite)
Applied Radiation And Isotopes (ISSN: 1872-9800, 0969-8043, 0969-8043linking), 2011 Jan; 69(1): 52-55.
Impact Factor: 1.172
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Vacca G, Liuzzi R, Amato L, Orefice G, Colao A, Brescia Morra V
* Growth Hormone Axis In Early Multiple Sclerosis Patients Before And After 2 Years Treatment With Interferon Beta-1b - An Interim Analysis (97 visite)
Proceedings Of The Xlii Meeting Of The Italian Society Of Neurology, 2011; nd: 360-360.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Strianese D, Tranfa F, Finelli M, De Renzo A, Staibano S, Schiemer R, Cardone D, Pacelli R, Perna F, Mascolo M, De Rosa G, Bonavolonta G
* Hepatitis C virus infection in ocular adnexal lymphomas (80 visite)
Arch Ophthalmol (ISSN: 1538-3601, 0003-9950), 2010 Oct; 128(10): 1295-1299.
Impact Factor: 3.516
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A,  Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (152 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Palmieri G. A
* A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient (91 visite)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Jul; 23(3): 951-954.
Impact Factor: 2.685
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (165 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP
* Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications (142 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2010 Apr 8; 5(4): N/D-N/D.
Impact Factor: 4.411
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (108 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G, Supuran CT
* Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target (161 visite)
Biochim Biophys Acta (ISSN: 1570-9639, 0006-3002, 0925-4439), 2010 Feb; 1804(2): 404-409.
Impact Factor: 2.773
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (112 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

Guler OO, De Simone G, Supuran CT
* Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (201 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2010; 17(15): 1516-1526.
Impact Factor: 4.63
Dettagli    Esporta in BibTeX    Esporta in EndNote

Merlino A, Russo Krauss I, Perillo M, Mattia CA, Ercole C, Picone D, Vergara A, Sica F
* Toward an Antitumor Form of Bovine Pancreatic Ribonuclease: The Crystal Structure of Three Noncovalent Dimeric Mutants (104 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2009 Dec; 91(12): 1029-1037.
Impact Factor: 2.605
Dettagli    Esporta in BibTeX    Esporta in EndNote

Farina AR, Tacconelli A, Cappabianca L, Cea G, Chioda A, Romanelli A, Pensato S, Pedone C, Gulino A, Mackay AR
* The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells (107 visite)
Oncogene (ISSN: 1476-5594, 0950-9232), 2009 Nov 19; 28(46): 4075-4094.
Impact Factor: 7.135
Dettagli    Esporta in BibTeX    Esporta in EndNote

Farina AR, Tacconelli A, Cappabianca L, Cea G, Panella S, Chioda A, Romanelli A, Pedone C, Gulino A, Mackay AR
* The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability (134 visite)
Mol Cell Biol (ISSN: 1098-5549, 0270-7306), 2009 Sep 1; 29(17): 4812-4830.
Impact Factor: 6.057
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cittadini A, Saldamarco L, Marra AM, Arcopinto M, Carlomagno G, Imbriaco M, Del Forno D, Vigorito C, Merola B, Oliviero U, Fazio S, Sacca L
* Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction (121 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2009 Sep; 94(9): 3329-3336.
Impact Factor: 6.202
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Gasperi M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao A, Morra VB
* Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis (131 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Sep; 15(9): 1402-1406.
Impact Factor: 3.279
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Longanesi-cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V
* Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis (136 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1535-7163, 1538-8514electronic, 1535-7163linking), 2009 Sep; 8(9): 2708-2717.
Impact Factor: 4.953
Dettagli    Esporta in BibTeX    Esporta in EndNote

Illario M, Monaco S, Cavallo AL, Esposito I, Formisano P, D'Andrea LD, Cipolletta E, Trimarco B, Fenzi G, Rossi G, Vitale M
* Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake (84 visite)
Cell Signal Cellular Signalling (ISSN: 0898-6568), 2009 May; 21(5): 786-792.
Impact Factor: 4.094
Dettagli    Esporta in BibTeX    Esporta in EndNote

Peca C, Pacelli R, Elefante A, Del Basso De Caro ML, Vergara P, Mariniello G, Giamundo A, Maiuri F
* Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? (118 visite)
Clin Neurol Neurosurg (ISSN: 0303-8467), 2009 May; 111(4): 331-334.
Impact Factor: 1.303
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Double-Blind, Placebo-Controlled, Randomized Trial of Growth Hormone as Add-On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: Preliminary MRS, Hormonal, and Population Analysis (133 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sacca F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Carotenuto B, Marsili A, Palma V, Bresciamorra V, Brunetti A, De Michele G, Filla A, Salvatore M
* A Randomized Trial of Growth Hormone as Add. On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis (88 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 76(9): N/D-N/D.
Impact Factor: 8.172
Dettagli    Esporta in BibTeX    Esporta in EndNote

Morisco A, Accardo A, Gianolio E, Tesauro D, Benedetti E, Morelli G
* Micelles derivatized with octreotide as potential target-selective contrast agents in MRI (113 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2009 Mar; 15(3): 242-250.
Impact Factor: 1.807
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zaccaro L, Del Gatto A, Pedone C, Saviano M
* Peptides for tumour therapy and diagnosis: current status and future directions (216 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2009 Mar; 16(7): 780-795.
Impact Factor: 4.708
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciaccio C, Tundo GR, Grasso G, Spoto G, Marasco D, Ruvo M, Gioia M, Rizzarelli E, Coletta M
* Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity (135 visite)
J Mol Biol (ISSN: 1089-8638, 0022-2836, 1089-8638electronic), 2009 Feb 6; 385(5): 1556-1567.
Impact Factor: 3.871
Dettagli    Esporta in BibTeX    Esporta in EndNote

Merlino A, Avella G, Di Gaetano S, Arciello A, Piccoli R, Mazzarella L, Sica F
* Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant (92 visite)
Protein Sci (ISSN: 0961-8368, 1469-896xelectronic, 0961-8368linking), 2009 Jan; 18(1): 50-57.
Impact Factor: 2.937
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Campanile A, Santulli G, Leggiero E, Pastore L, Trimarco B, Iaccarino G
* A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity (110 visite)
Mol Cancermolecular Cancer (ISSN: 1476-4598), 2009; 8: N/D-N/D.
Impact Factor: 4.16
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, Erra P, Pellegrino T, Nardelli A, Milone F, Di Giorgio E, Faggiano A, Castaldi E, Ortosecco G, Speranza A, Klain M, Colao A, Salvatore M, Pace L
* Efficacy and Toxicity of Peptide Receptor Radionuclide Therapy (PRRT) using medium-high activities of Y-90-DOTA-Octreotate (Y-90-DOTATATE) in patients with tumours expressing somatostatin receptors (SSTR) (102 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marasco D, Perretta G, Sabatella M, Ruvo M
* Past and Future Perspectives of Synthetic Peptide Libraries (115 visite)
Curr Protein Pept Sci (ISSN: 1389-2037), 2008 Oct; 9(5): 447-467.
Impact Factor: 3.011
Dettagli    Esporta in BibTeX    Esporta in EndNote

Woo LWL, Fischer DS, Sharland CM, Trusselle M, Foster PA, Chander SK, Di Fiore A, Supuran CT, De Simone G, Purohit A, Reed MJ, Potter BVL
* Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (124 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1535-7163, 1538-8514electronic), 2008 Sep; 7(8): 2435-2444.
Impact Factor: 5.003
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, Di Fiore A, De Simone G
* Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity (132 visite)
Expert Opin Emerg Drugsexpert Opinion On Emerging Drugs (ISSN: 1472-8214), 2008 Jun; 13(2): 383-392.
Impact Factor: 3.08
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sbardella G, Castellano S, Vicidomini C, Rotili D, Nebbioso A, Miceli M, Altucci L, Mai A
* Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases (87 visite)
Bioorganic & Medicinal Chemistry Letters (ISSN: 0960-894x), 2008 May 1; 18(9): 2788-2792.
Impact Factor: 2.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B
* Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease (165 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.
Impact Factor: 1.888
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents (130 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2008 Mar 13; 51(5): 1295-1308.
Impact Factor: 4.898
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colangelo AM, Bianco MR, Vitagliano L, Cavaliere C, Cirillo G, De Gioia L, Diana D, Colombo D, Redaelli C, Zaccaro L, Morelli G, Papa M, Sarmientos P, Alberghina L, Martegani E
* A New Nerve Growth Factor (ngf)-Mimetic Peptide Active On Neuropathic Pain In Rats (146 visite)
J Neurosci (ISSN: 0270-6474, 0270-0647, 1529-2401), 2008 Mar 12; 28(11): 2698-2709.
Impact Factor: 7.452
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G, Di Fiore A, Supuran CT
* Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? (122 visite)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1381-6128, 1873-4286), 2008 Mar; 14(7): 655-660.
Impact Factor: 4.399
Dettagli    Esporta in BibTeX    Esporta in EndNote

Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R
* The role of insulin receptors and IGF-I receptors in cancer and other diseases (1094 visite)
Archives Of Physiology And Biochemistry (ISSN: 1381-3455), 2008 Feb; 114(1): 23-37.
Impact Factor: 2.028
Dettagli    Esporta in BibTeX    Esporta in EndNote

Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L
* The role of membrane glycoprotein plasma cell antigen 1 ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities (172 visite)
Endocrine Reviews (ISSN: 0163-769x), 2008 Feb; 29(1): 62-75.
Impact Factor: 18.562
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, De Simone G
Carbonic anhydrases--an overview (114 visite)
Curr Pharm Des, 2008; 14(7): 603-614.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (132 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (194 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (138 visite)
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messere A, Fabbri E, Borgatti M, Gambari R, Di Blasio B, Pedone C, Romanelli A
* Antiproliferative activity of Pt(II) and Pd(II) phosphine complexes with thymine and thymidine (89 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2007 Feb; 101(2): 254-260.
Impact Factor: 3.663
Dettagli    Esporta in BibTeX    Esporta in EndNote

Minopoli G, Stante M, Napolitano F, Telese F, Aloia L, De Felice M, Di Lauro R, Pacelli R, Brunetti A, Zambrano N, Russo T
* Essential roles for Fe65, Alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage (111 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2007 Jan 12; 282(2): 831-835.
Impact Factor: 5.581
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (92 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Tesauro D, Mangiapia G, Pedone C, Morelli G
* Nanostructures by self-assembling peptide amphiphile as potential selective drug carriers (137 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2007; 88(2): 115-121.
Impact Factor: 2.389
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (308 visite)
J Med Chem (ISSN: 0022-2623print, 0022-2623linking, 1520-4804), 2006 Dec 28; 49(26): 7683-7696.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mai A, Rotili D, Tarantino D, Ornaghi P, Tosi F, Vicidomini C, Sbardella G, Nebbioso A, Miceli M, Altucci L, Filetici P
* Small-molecule inhibitors of histone acetyltransferase activity: Identification and biological properties (121 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Nov 16; 49(23): 6897-6907.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT
* Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (120 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2006 Jun 28; 128(25): 8329-8335.
Impact Factor: 7.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Renzo A, Perna F, Persico M, Mainolfi C, Pace L
* 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma (85 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2006 Jun; 133(6): 580-580.
Impact Factor: 4.498
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (105 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fiory F, Alberobello AT, Miele C, Oriente F, Esposito I, Corbo V, Ruvo M, Tizzano B, Rasmussen TE, Gammeltoft S, Formisano P, Beguinot F
* Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling (128 visite)
Mol Cell Biol (ISSN: 0270-7306, 1098-5549), 2005 Dec; 25(24): 10803-10814.
Impact Factor: 7.093
Dettagli    Esporta in BibTeX    Esporta in EndNote

Menchise V, De Simone G, Alterio V, Di Fiore A, Pedone C, Scozzafava A, Supuran CT
* Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (141 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2005 Sep 8; 48(18): 5721-5727.
Impact Factor: 4.926
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G
* Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency (122 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2005 Sep; 90(9): 5146-5155.
Impact Factor: 6.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M
* Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma (137 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Sep; 49(3): 281-285.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, Manfioletti G, Barbetti F, Brunetti A, Croce CM, Fusco A, Brunetti A
* Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice (106 visite)
Nat Med (ISSN: 1078-8956, 0034-7264), 2005 Jul; 11(7): 765-773.
Impact Factor: 28.878
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cozzolino R, Palladino P, Rossi F, Cali G, Benedetti E, Laccetti P
* Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis (165 visite)
Carcinogenesis (ISSN: 0143-3334), 2005 Apr; 26(4): 733-739.
Impact Factor: 5.108
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, Mainenti PP, De Rosa G, Colao A, Contegiacomo A
* Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR (110 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2005 Apr; 28(4): 371-378.
Impact Factor: 1.496
Dettagli    Esporta in BibTeX    Esporta in EndNote

Savastano S, Pivonello R, Acampa W, Salvatore M, Lombardi G, Colao A, Fenzi G
* Recombinant thyrotropin-induced orbital uptake of [In-111-diethylenetriamine-pentacetic acid-D-phe(1)]octreotide in a patient with inactive Graves' ophthalmopathy (96 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2005 Apr; 90(4): 2440-2444.
Impact Factor: 6.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Tedesco I, Iacomino G, Palumbo R, Galano G, Russo GL
* Dietary phytochemicals in chemoprevention of cancer (107 visite)
Curr Med Chem (ISSN: 1568-0134), 2005; 5(1): 61-72.
Impact Factor: 3.715
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G
* The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study (114 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2004 Dec; 89(12): 5998-6004.
Impact Factor: 5.778
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vitale RM, Pedone C, De Benedetti PG, Fanelli F
* Structural features of the inactive and active states of the melanin-concentrating hormone receptors: Insights from molecular simulations (179 visite)
Proteins (ISSN: 0887-3585, 1097-0134, 1097-0134electronic), 2004 Sep 15; 56(3): 430-448.
Impact Factor: 4.429
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Salvatore M
* Tc-99m-MIBI in the evaluation of breast cancer biology (215 visite) (PDF 68 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(SUPPL.1): S88-S88.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rossi F, Zanotti G, Saviano M, Iacovino R, Palladino P, Saviano G, Amodeo P, Tancredi T, Laccetti P, Corbier C, Benedetti E
* New antitumour cyclic astin analogues: Synthesis, conformation and bioactivity (103 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 Feb; 10(2): 92-102.
Impact Factor: 1.652
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (127 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spinelli L, Petretta M, Verderame G, Carbone G, Venetucci AA, Petretta A, Acampa W, Bonaduce D, Colao A, Cuocolo A
* Left ventricular diastolic function and cardiac performance during exercise in patients with acromegaly (115 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2003 Sep; 88(9): 4105-4109.
Impact Factor: 5.873
Dettagli    Esporta in BibTeX    Esporta in EndNote

Andretta C, Catalano L, Pace L, Fonti R, Annunziata G, Rotoli B
* 99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients [2] (99 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2003 Jun; 44(6): 1081-1082.
Impact Factor: 1.163
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (118 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (96 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G
* Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide (124 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2003 Feb; 58(2): 169-176.
Impact Factor: 2.767
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (141 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Del Vecchio S, Quarantelli M, Ibello F, Pellegrino T, Salvatore M
* Radiolabeled somatostatin analogs in the diagnosis and staging of neuroendocrine tumors (103 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2003; 26(8Suppl): 60-62.
Impact Factor: 1.621
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tabbì G, Cassino C, Cavigiolio G, Colangelo D, Ghiglia A, Viano I, Osella D
* Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process (131 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2002 Dec 19; 45(26): 5786-5796.
Impact Factor: 4.566
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Spinelli L, Cuocolo A, Spiezia S, Pivonello R, Di Somma C, Bonaduce D, Salvatore M, Lombardi G
* Cardiovascular consequences of early-onset growth hormone excess (126 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2002 Jul; 87(7): 3097-3104.
Impact Factor: 5.199
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marino M, Rossi M, Ruvo M, Fassina G
* Novel molecular targets for systemic lupus erythematosus (105 visite)
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.
Impact Factor: 3.597
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G
* The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: A 12-month prospective study (122 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2002 Mar; 87(3): 1088-1093.
Impact Factor: 5.199
Dettagli    Esporta in BibTeX    Esporta in EndNote

Danforth Dn JR, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD
* The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer (93 visite)
Breast Cancer Res Tr Kluwer Academic Publishers (ISSN: 0167-6806), 2002; 75(2): 135-146.
Impact Factor: 3.132
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G
* Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients, with GH deficiency (122 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2001 May; 86(5): 1874-1881.
Impact Factor: 5.16
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Morte A, Pivonello R, Salvatore M, Lombardi G
* Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance (97 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2001 Apr; 86(4): 1551-1557.
Impact Factor: 5.16
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Marzullo P, Ferone D, Spinelli L, Cuocolo A, Bonaduce D, Salvatore M, Boerlin V, Lancranjan I, Lombardi G
Cardiovascular effects of depot long-acting somatostatin analog sandostatin LAR in acromegaly (121 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2000 Sep; 85(9): 3132-3140.
Impact Factor: 5.447
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Salvatore M
Scintigraphic detection of multidrug resistance in cancer (97 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2000 Sep; 15(4): 327-337.
Impact Factor: 0.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A
Cardiac effect of thyrotoxicosis in acromegaly (108 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2000 Apr; 85(4): 1426-1432.
Impact Factor: 5.447
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte A, Pivonello R, Nicolai E, Salvatore M, Lombardi G
Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study (100 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2000 Apr; 52(4): 447-455.
Impact Factor: 2.922
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colasanti A, Kisslinger A, Liuzzi R, Quarto M, Riccio P, Roberti G, Tramontano D, Villani F
Hypericin photosensitization of tumor and metastatic cell lines of human prostate (64 visite)
J Photochem Photobiol B (ISSN: 1011-1344print, 1011-1344linking), 2000 Feb; 54(2-3): 103-107.
Impact Factor: 1.529
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte A, Nicolai E, Lucci R, Salvatore M, Lombardi G
Impaired cardiac performance in elderly patients with growth hormone deficiency (92 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1999 Nov; 84(11): 3950-3955.
Impact Factor: 5.805
Dettagli    Esporta in BibTeX    Esporta in EndNote

Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB
Principles of chemoradiation: Theoretical and practical considerations (104 visite)
Oncology (ISSN: 0890-9091), 1999 Oct; 13(10SUPPL.5): 11-22.
Impact Factor: 0.933
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (116 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte A, Petretta M, Salvatore M, Lombardi G
Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study (101 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1999 May; 84(5): 1518-1523.
Impact Factor: 5.805
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (116 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
Impact Factor: 0.957
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly (87 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1999 Jan; 84(1): 17-23.
Impact Factor: 5.805
Dettagli    Esporta in BibTeX    Esporta in EndNote

Imbriaco M, De Iuri A, Camera L
Isolated uterine relapse in a child with acute lymphoblastic leukemia (75 visite)
Ajr Am J Roentgenol (ISSN: 0361-803x), 1998 Oct; 171(4): 1166-1167.
Impact Factor: 2.179
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M
Different patterns of technetium-99m sestamibi uptake in multiple myeloma (119 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.
Impact Factor: 2.564
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (139 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (139 visite)
Journal Of Clinical Oncology (ISSN: 0732-183x), 1998 May; 16(5): 1677-1683.
Impact Factor: 8.228
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caracò C, Bianco RA, Muto P, Salvatore M
In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy (110 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1998 Apr; 39(4): 634-639.
Impact Factor: 3.064
Dettagli    Esporta in BibTeX    Esporta in EndNote

Longobardi S, Cuocolo A, Merola B, Di Rella F, Colao A, Nicolai E, Cardei S, Salvatore M, Lombardi G
Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency (88 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 1998 Feb; 48(2): 137-143.
Impact Factor: 3.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas (103 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 1998 Jan; 83(1): 248-252.
Impact Factor: 5.641
Dettagli    Esporta in BibTeX    Esporta in EndNote

Klain M, Cuocolo A, Salvatore M, Maurea S
Tetrofosmin thyroid scintigraphy [1] (84 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998; 25(7): 816-816.
Impact Factor: 2.564
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lombardi G, Colao A, Cuocolo A, Longobardi S, Di Somma C, Orio F, Merola B, Nicolai E, Salvatore M
Cardiological aspects of growth hormone and insulin-like growth factor- (94 visite)
J Pediatr Endocrinol Metab (ISSN: 0334-018x), 1997 Nov; 10(6): 553-560.
Impact Factor: 0.481
Dettagli    Esporta in BibTeX    Esporta in EndNote

Wink DA, Cook JA, Christodoulou D, Krishna MC, Pacelli R, Kim S, DeGraff W, Gamson J, Vodovotz Y, Russo A, Mitchell JB
Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin (92 visite)
Nitric Oxide Biology And Chemistry (ISSN: 1089-8603), 1997 Feb; 1(1): 88-94.
Impact Factor: 2.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (108 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iaffaioli RV, Facchini G, Tortoriello A, Scala S, Pacelli R, La Mura G, Pagliarulo C, Palmieri G, Caponigro F
Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma (108 visite)
J Exp Ther Oncol (ISSN: 1359-4117), 1996 Jul; 1(4): 226-230.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lastoria S, Muto P, Acampa W, Caraco C, Vergara E, Varrella P, Pezzullo L, Ionna F, Mozzillo N, ListerJames J, Salvatore M
Somatostatin receptor scintigraphy (SRS) with technetium-99m labeled synthetic peptides in melanoma (107 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 May; 37(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (112 visite)
Q J Nucl Med (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
Impact Factor: 2.125
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmeieri G, Lastoria S, Vergara E, Varrella P, Acampa W, Salvatore M, Bianco AR
Diagnosis and treatment of thymoma by octreotide (81 visite)
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1995; 36(0): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Muto P, Lastoria S, Vergara E, Caraco C, Varrella P, Bernardy JD, Acampa W, Salvatore M
Tc-99m labeled somatostatin analogs to image tumors expressing specific receptors (83 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

LASTORIA S, COLAO A, VERGARA E, FERONE D, VARRELLA P, MEROLA B, ACAMPA W, LOMBARDI G, SALVATORE M
IN-111 OCTREOTIDE UPTAKE LEVELS IN PITUITARY-ADENOMAS TO PREDICT THE RESPONSIVENESS TO CHRONIC OCTREOTIDE TREATMENT (70 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW DISEASES EXPRESSING SOMATOSTATIN RECEPTORS BY IN-111 OCTREOTIDE (82 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW NEOPLASTIC LESIONS EXPRESSING SOMATOSTATIN RECEPTORS USING IN-111 OCTREOTIDE (99 visite)
Posters Tomes 1 4proceedings Of The Xvi International Cancer Congress Free Papers And, 1994; N/D: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cucinotta V, Mangano A, Nobile G, Santoro AM, Vecchio G
New platinum(II) complexes of β-cyclodextrin diamine derivatives and their antitumor activity (100 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Nov 15; 52(3): 183-190.
Impact Factor: 1.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Arena G, Bindoni M, Cardile V, Maccarrone G, Riello MC, Rizzarelli E, Sciuto S
Cytotoxic and cytostatic activity of copper(II) complexes. Importance of the speciation for the correct interpretation of the in vitro biological results (137 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Apr 1; 50(1): 31-45.
Impact Factor: 1.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

FRITTITTA L, VIGNERI R, PAPA V, GOLDFINE I, GRASSO G, TRISCHITTA V
Structural and functional studies of insulin receptors in human breast cancer (105 visite)
Breast Cancer Res Tr Kluwer Academic Publishers (ISSN: 0167-6806), 1993; 25(1): 73-82.
Impact Factor: 2.43
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (118 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (82 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Trischitta V,  Brunetti A, Chiavetta A, Benzi L, Papa V, Vigneri R
Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients (88 visite)
Diabetesdiabetes (ISSN: 0012-1797), 1989 Dec; 38(12): 1579-1584.
Impact Factor: 8.675
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pezzino V, Papa V, Trischitta V,  Brunetti A, Goodman PA, Treutelaar MK, Williams JA, Maddux BA, Vigneri R, Goldfine ID
Human insulin receptor radioimmunoassay: Applicability to insulin-resistant states (85 visite)
Am J Physiol Endocrinol Metab (ISSN: 0002-9513), 1989 Sep; 257(3): N/D-N/D.
Impact Factor: 3.116
Dettagli    Esporta in BibTeX    Esporta in EndNote

Trischitta V, Wong KY,  Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (88 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (138 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote



202 Records (174 escludendo Abstract e Conferenze).
Impact factor totale: 842.427 (738.431 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 828.174 (720.337 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Gennaro Angrisano in data Tuesday 06 October 2015, 11:18:28
690 visite. Ultima visita in data Friday 15 February 2019, 8:27:45

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Monday 18 February 2019, 17:23:40